Glossary  pp. 264-274


By Adrian Carter and Wayne Hall

Reference Type: bibliography

Abelson, J. L. Curtis, G. C. Sagher, O. 2005 Deep brain stimulation for refractory obsessive-compulsive disorder Biological Psychiatry 57 510
Abler, B. Walter, H. Erk, S. 2005 Neural correlates of frustration Neuroreport 16 669
Academy of Medical Sciences 2008 Brain Science, Addiction and Drugs London Academy of Medical Sciences
Addolorato, G. Leggio, L. Ferrulli, A. 2007 Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study Lancet 370 1915
Adhikari, B. Kahende, J. Malarcher, A. 2008 Smoking-attributable mortality, years of potential life lost, and productivity losses – United States, 2000–2004 Morbidity and Mortality Weekly Report 57 1226
Adler, M. W. 1995 Human subject issues in drug-abuse research Drug and Alcohol Dependence 37 167
Agid, Y. Schupbach, M. Gargiulo, M. 2006 Neurosurgery in Parkinson's disease: the doctor is happy, the patient less so? Journal of Neural Transmission. Supplementum 70 409
Ahmed, S. H. 2010 Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction Neuroscience & Biobehavioral Reviews 35 172
AIHW 2008 National Drug Strategy Household Survey: Detailed Findings Canberra Australian Institute of Health and Welfare
Ainslie, G. 2000 A research-based theory of addictive motivation Law and Philosophy: An International Journal for Jurisprudence and Legal Philosophy 19 77
Ainslie, G. 2001 Breakdown of Will New York Cambridge University Press
Akil, H. Brenner, S. Kandel, E. 2010 Medicine. The future of psychiatric research: genomes and neural circuits Science 327 1580
Alexander, B. K. Beyerstein, B. L. Hadaway, P. F. 1981 Effect of early and later colony housing on oral ingestion of morphine in rats Pharmacology, Biochemistry and Behavior 15 571
Alexander, B. K. Coambs, R. B. Hadaway, P. F. 1978 The effect of housing and gender on morphine self-administration in rats Psychopharmacology 58 175
Ali, R. Christie, P. Lenton, S. 1999 The Social Impacts of the Cannabis Expiation Notice Scheme in South Australia. Summary Report Presented to the Ministerial Council on Drug Strategy Canberra Commonwealth Department of Health and Aged Care
Alonso-Zaldivar, R. 2008
Alper, J. S. Beckwith, J. 1993 Genetic fatalism and social-policy: the implications of behavior genetics research Yale Journal of Biology and Medicine 66 511
Amato, L. Davoli, M. Perucci, C. A. 2005 An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research Journal of Substance Abuse Treatment 28 321
Ambermoon, P. Carter, A. Hall, W. 2011 Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field Addiction 106 283
American Psychiatric Association 2000 Diagnostic and Statistical Manual of Mental Disorders – Text Revision (DSM-IV-TR) Washington, DC American Psychiatric Association
Anand, S. Hotson, J. 2002 Transcranial magnetic stimulation: neurophysiological applications and safety Brain and Cognition 50 366
ANCD 2005 Key Principles for the Reporting of Drug Issues Canberra Australian National Council on Drugs
ANCD 2007 The Australian Alcohol and Other Drugs Charter Canberra Australian National Council on Drugs
Anderer, S. J. 1992 Introduction to the symposium: integrating legal and psychological perspectives on the right to personal autonomy Villanova Law Review 37 1536
Anderlik, M. R. Rothstein, M. A. 2001 Privacy and confidentiality of genetic information: what rules for the new science? Annual Review of Genomics and Human Genetics 2 401
Andlin-Sobocki, P. Rehm, J. 2005 Cost of addiction in Europe European Journal of Neurology 12 28
Angermeyer, M. C. Matschinger, H. 2005 Have there been any changes in the public's attitudes towards psychiatric treatment? Results from representative population surveys in Germany in the years 1990 and 2001 Acta Psychiatrica Scandinavica 111 68
Anon 2005 How volunteering for an MRI scan changed my life Nature 434 17
Anthony, J. C. Warner, L. Kessler, R. C. 1994 Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey Experimental and Clinical Psychopharmacology 2 244
Anton, R. F. Oroszi, G. O'Malley, S. 2008 An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study Archives of General Psychiatry 65 135
Aos, S. Miller, M. Drake, E. 2006 Evidence-Based Public Policy Options to Reduce Future Prison Construction, Criminal Justice Costs, and Crime Rates Olympia, WA Washington State Institute for Public Policy
Appelbaum, P. S. 2010 Law and psychiatry: genetic discrimination in mental disorders: the impact of the genetic information nondiscrimination act Psychiatric Services 61 338
Appelbaum, P. S. Roth, L. H. Lidz, C. W. 1987 False hopes and best data: consent to research and the therapeutic misconception Hastings Center Report 17 20
Ardouin, C. Voon, V. Worbe, Y. 2006 Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation Movement Disorders 21 1941
Aronowitz, D. 1967 Civil commitment of narcotics addicts Columbia Law Review 67 405
Ascher, J. A. Cole, J. O. Colin, J. N. 1995 Bupropion: a review of its mechanism of antidepressant activity Journal of Clinical Psychiatry 56 395
Ashcroft, R. 2005 Making sense of dignity Journal of Medical Ethics 31 679
Ashcroft, R. Campbell, A. Capps, B. 2007 Ethical aspects of developments in neuroscience and drug addiction D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 439 London Academic Press
Ashcroft, R. Franey, C. 2004 Further ethical and social issues in using a cocaine vaccine: response to Hall and Carter Journal of Medical Ethics 30 341
Audrain, J. Boyd, N. R. Roth, J. 1997 Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial Addictive Behaviors 22 741
Australian Press Council 2001
Avery, L. Campbell, S. 1941 Shock therapy as an aid to the withdrawal of morphine in addiction Disorders of the Nervous System 2 333
Babor, T. Caetano, R. Casswell, S. 2003 Alcohol: No Ordinary Commodity. Research and Public Policy Oxford Oxford University Press
Babor, T. Miller, P. Edwards, G. 2010 Vested interests, addiction research and public policy Addiction 105 4
Backlar, P. 1996 Genes and behavior: will genetic information change the way we see ourselves? Community Mental Health Journal 32 205
Badenoch, J. 2002 A death following ultra-rapid opiate detoxification: the General Medical Council adjudicates on a commercialized detoxification Addiction 97 475
Balasubramaniam, V. Kanaka, T. S. Ramanujam, P. B. 1973 Stereotaxic cingulumotomy for drug addiction Neurology India 21 63
Baldwin, R. 1979 Proposals for the Drug and Alcohol Court Assessment Programme Sydney NSW Drug and Alcohol Authority Internal Paper
Baler, R. D. Volkow, N. D. 2006 Drug addiction: the neurobiology of disrupted self-control Trends in Molecular Medicine 12 559
Balfour, D. J. 2004 The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected] Nicotine and Tobacco Research 6 899
Ball, A. L. 2007 HIV, injecting drug use and harm reduction: a public health response Addiction 102 684
Ball, D. 2008 Addiction science and its genetics Addiction 103 360
Ball, D. Collier, D. 2002 Substance misuse P. McGuffin M. J. Owen I. I. Gottesman Psychiatric Genetics and Genomics 267 Oxford Oxford University Press
Ball, D. Pembrey, M. Stevens, D. 2007 Genomics D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 89 London Academic Press
Ballard, P. Radley, A. 2009 Give it up for baby: a smoking cessation intervention for pregnant women in Scotland Cases in Public Health Communication & Marketing 3 147
Ballon, B. C. Skinner, W. 2008 Attitude is a little thing that makes a big difference: reflection techniques for addiction psychiatry training Academic Psychiatry 32 218
Baltuch, G. H. Stern, M. B. 2007 Deep Brain Stimulation for Parkinson's Disease New York Informa Healthcare
Barclay, G. A. 1964 The Keeley League Journal of the Illinois State Historical Society (1908–1984) 57 341
Barnes, R. E. 2000 Reefer madness: legal and moral issues surrounding the medical prescription of marijuana Bioethics 14 16
Barrett, D. Nowak, M. 2009 The United Nations and drug policy: towards a human rights-based approach A. Constantinides N. Zaikos The Diversity of International Law: Essays in Honour of Professor Kalliopi K. Koufa 449 Boston Martinus Nijhoff Publishers
Baudelaire, C. 2002 On Wine and Hashish London Hesperus
Bauer, R. Pohl, S. Klosterkotter, J. 2008 [Deep brain stimulation in the context of addiction – a literature-based systematic evaluation] Fortschritte der Neurologie-Psychiatrie 76 396
Baumeister, R. F. 2003 Ego depletion and self-regulation failure: a resource model of self-control Alcoholism, Clinical and Experimental Research 27 281
BBC News 2004
BBC News 2007
Beauchamp, T. L. Childress, J. F. 2001 Principles of Biomedical Ethics New York Oxford University Press
Bechara, A. 2001 Neurobiology of decision-making: risk and reward Seminars in Clinical Neuropsychiatry 6 205
Bechara, A. 2005 Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective Nature Neuroscience 8 1458
Bechara, A. Dolan, S. Denburg, N. 2001 Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers Neuropsychologia 39 376
Becker, A. Grecksch, G. Brodemann, R. 2000 Morphine self-administration in mu-opioid receptor-deficient mice Naunyn-Schmiedeberg's Archives of Pharmacology 361 584
Begg, S. Vos, T. Barker, B. 2007 The Burden of Disease and Injury in Australia 2003 Canberra Australian Institute of Health and Welfare
Belenko, S. 2002 The challenges of conducting research in drug treatment court settings Substance Use & Misuse 37 1635
Bell, E. Maxwell, B. Sadikot, A. 2010 Healthcare providers' perspectives and approaches Journal of Clinical Ethics 21 113
Bell, J. Chan, J. Kuk, A. 1995 Investigating the effect of treatment philosophy on outcome of methadone maintenance Addiction 90 823
Bell, J. Hall, W. Byth, K. 1992 Changes in criminal activity after entering methadone maintenance British Journal of Addiction 87 251
Benabid, A. L. Pollak, P. Seigneuret, E. 1993 Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias Acta Neurochirurgica. Supplementum 58 39
Bennett, P. Smith, S. 2007 Genetics, insurance and participation: how a citizen's jury reached its verdict Social Science and Medicine 64 2487
Bentham, J. 1988 The Principles of Morals and Legislation Buffalo, NY Prometheus Books
Berke, J. D. 2003 Learning and memory mechanisms involved in compulsive drug use and relapse Methods in Molecular Medicine 79 75
Berke, J. D. Hyman, S. E. 2000 Addiction, dopamine, and the molecular mechanisms of memory Neuron 25 515
Berridge, K. C. 2007 The debate over dopamine's role in reward: the case for incentive salience Psychopharmacology 191 391
Berridge, K. C. Robinson, T. E. 1998 What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Reviews 28 309
Bersoff, D. N. 1992 Autonomy for vulnerable populations: the Supreme Court's reckless disregard for self-determination and social science Villanova Law Review 37 1569
Bigelow, G. E. Brooner, R. Walsh, S. 1994 Community outcomes following research exposure to cocaine or opioids L. Harris Problems of Drug Dependence: Proceedings of the 56th Annual Scientific Meeting of the College on Problems of Drug Dependence (Volume 2) 354 Baltimore, MD National Institute on Drug Abuse
Billings, P. R. Kohn, M. A. Decuevas, M. 1992 Discrimination as a consequence of genetic testing American Journal of Human Genetics 50 476
Bjorklund, A. Dunnett, S. B. 2007 Fifty years of dopamine research Trends in Neurosciences 30 185
Blakemore, C. 2002 From the “public understanding of science” to scientists' understanding of the public S. J. Marcus Neuroethics: Mapping the Field 211 New York Dana Press
Boeijinga, P. H. Parot, P. Soufflet, L. 2004 Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence Neuropsychobiology 50 71
Bonese, K. F. Wainer, B. H. Fitch, F. W. 1974 Changes in heroin self-administration by a rhesus monkey after morphine immunisation Nature 252 708
Bonson, K. R. Grant, S. J. Contoreggi, C. S. 2002 Neural systems and cue-induced cocaine craving Neuropsychopharmacology 26 376
Brandt, A. M. 2007 The Cigarette Century Atlanta, GA Basic Books
Brebner, K. Ahn, S. Phillips, A. G. 2005 Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates Psychopharmacology 177 409
Brodie, J. D. Figueroa, E. Laska, E. M. 2005 Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction Synapse 55 122
Brody, B. A. 1998 The Ethics of Biomedical Research: An International Perspective New York Oxford University Press
Brody, B. A. 2003 Taking Issue: Pluralism and Casuistry in Bioethics Washington, DC Georgetown University Press
Brown, S. M. Manuck, S. B. Flory, J. D. 2006 Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control Emotion 6 239
Bruce, R. D. Schleifer, R. A. 2008 Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention International Journal of Drug Policy 19 17
Bruijnzeel, A. W. Gold, M. S. 2005 The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence Brain Research. Brain Research Reviews 49 505
Bush, G. Whalen, P. J. Rosen, B. R. 1998 The Counting Stroop: an interference task specialized for functional neuroimaging – validation study with functional MRI Human Brain Mapping 6 270
Cairns, R. Maddock, C. Buchanan, A. 2005 Reliability of mental capacity assessments in psychiatric in-patients British Journal of Psychiatry 187 372
Calabresi, P. Picconi, B. Tozzi, A. 2007 Dopamine-mediated regulation of corticostriatal synaptic plasticity Trends in Neurosciences 30 211
Callahan, D. 2003 Principlism and communitarianism Journal of Medical Ethics 29 287
Campbell, D. E. Fleischman, A. R. 1992 Ethical challenges in medical care for the pregnant substance abuser Clinical Obstetrics and Gynecology 35 803
Campbell, N. C. 2007 Discovering Addiction: The Science and Politics of Substance Abuse Research Ann Arbor University of Michigan Press
Canli, T. Amin, Z. 2002 Neuroimaging of emotion and personality: scientific evidence and ethical considerations Brain and Cognition 50 414
Cantin, L. Lenoir, M. Augier, E. 2010 Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction PLoS ONE 5 e11592
Caplan, A. 2002 No brainer: can we cope with the ethical ramifications of new knowledge of the human brain S. Marcus Neuroethics: Mapping the Field 95 San Francisco The Dana Press
Caplan, A. 2006 Ethical issues surrounding forced, mandated, or coerced treatment Journal of Substance Abuse Treatment 31 117
Caplan, A. 2008 Denying autonomy in order to create it: the paradox of forcing treatment upon addicts Addiction 103 1919
Caplan, A. Elliott, C. 2004 Is it ethical to use enhancement technologies to make us better than well? PLoS Medicine 1 e52
Cappella, J. N. Lerman, C. Romantan, A. 2005 News about genetics and smoking Communication Research 32 478
Capps, B. 2007 Authoritative regulation and the stem cell debate Bioethics Quarterly 22 43
Capps, B. Campbell, A. V. ter Meulen, R. 2008 Access to the UK Biobank Resource: Concepts of the Public Interest and the Public Good London Ethics and Governance Council of UK Biobank and the Wellcome Trust
Carlsten, C. Burke, W. 2006 Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations Journal of the American Medical Association 296 2480
Caron, L. Karkazis, K. Raffin, T. A. 2005 Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking Nicotine & Tobacco Research 7 181
Carpenter, M. J. Strange, C. Jones, Y. 2007 Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency Annals of Behavioral Medicine 33 22
Carter, A. Ambermoon, P. Hall, W. 2010
Carter, A. Bell, E. Racine, E. 2010
Carter, A. Capps, B. Hall, W. 2009 Addiction Neurobiology: Ethical and Social Implications Lisbon European Monitoring Centre for Drugs and Drug Addiction
Carter, A. Hall, W. 2007 The Ethical Use of Psychosocially Assisted Pharmacological Treatment of Opioid Dependence Geneva World Health Organization
Carter, A. Hall, W. 2007 The social implications of neurobiological explanations of resistible compulsions American Journal of Bioethics 7 15
Carter, A. Hall, W. 2008 Informed consent to opioid agonist maintenance treatment: recommended ethical guidelines International Journal of Drug Policy 19 79
Carter, A. Hall, W. 2008 The issue of consent in research that administers drugs of addiction to addicted persons Accountability in Research 15 209
Carter, A. Hall, W. 2011 Proposals to trial deep brain stimulation to treat addiction are premature Addiction 106 235
Casebeer, W. D. 2003 Natural Ethical Facts: Evolution, Connectionism, and Moral Cognition Cambridge, MA MIT Press
Caspi, A. Moffitt, T. E. 2006 Gene–environment interactions in psychiatry: joining forces with neuroscience Nature Reviews. Neuroscience 7 583
Cerny, E. H. Cerny, T. 2008 Anti-nicotine abuse vaccines in the pipeline: an update Expert Opinion on Investigational Drugs 17 691
Chambers, R. A. 2008 Impulsivity, dual diagnosis, and the structure of motivated behavior in addiction Behavioral and Brain Sciences 31 443
Chandler, R. K. Fletcher, B. W. Volkow, N. D. 2009 Treating drug abuse and addiction in the criminal justice system: improving public health and safety JAMA 301 183
Chapman, S. MacKenzie, R. 2010 The global research neglect of unassisted smoking cessation: causes and consequences PLoS Medicine 7
Charland, L. C. 2002 Cynthia's dilemma: consenting to heroin prescription American Journal of Bioethics 2 37
Chatterjee, A. 2004 Cosmetic neurology: the controversy over enhancing movement, mentation, and mood Neurology 63 968
Chatterjee, A. 2006 The promise and predicament of cosmetic neurology Journal of Medical Ethics 32 110
Chatterjee, A. 2007 Cosmetic neurology and cosmetic surgery: parallels, predictions, and challenges Cambridge Quarterly of Healthcare Ethics 16 129
Chavkin, W. 1996 Mandatory treatment for pregnant substance abusers: irrelevant and dangerous Politics and the Life Sciences 15 53
Chen, Y. C. Lu, R. B. Peng, G. S. 1999 Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele Alcoholism, Clinical and Experimental Research 23 1853
Chervenak, F. A. McCullough, L. B. 1997 Ethics in obstetrics and gynecology: an overview European Journal of Obstetrics and Gynecology 75 91
Childress, A. R. Mozley, P. D. McElgin, W. 1999 Limbic activation during cue-induced cocaine craving American Journal of Psychiatry 156 11
Childress, J. F. Faden, R. R. Gaare, R. D. 2002 Public health ethics: mapping the terrain Journal of Law Medicine & Ethics 30 170
Christensen, R. Kristensen, P. K. Bartels, E. M. 2007 Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials Lancet 370 1706
Chuck, A. Jacobs, P. Logus, J. W. 2005 Marginal cost of operating a positron emission tomography center in a regulatory environment International Journal of Technology Assessment in Health Care 21 442
Churchland, P. S. 1986 Neurophilosophy: Toward a Unified Science of the Mind-brain Cambridge, MA. MIT Press
Clancey, G. Howard, J. 2006 Diversion and criminal justice drug treatment: mechanism of emancipation or social control? Drug and Alcohol Review 25 377
Cohen, J. 2004 HIV/AIDS in China. Changing course to break the HIV–heroin connection Science 304 1434
Cohen, J. Csete, J. 2006 As strong as the weakest pillar: harm reduction, law enforcement and human rights International Journal of Drug Policy 17 101
Cohen, J. E. Amon, J. J. 2008 Health and human rights: concerns of drug users in detention in Guangxi Province, China PLoS Medicine 5 e234
Cohen, P. J. 1997 Immunization for prevention and treatment of cocaine abuse: legal and ethical implications Drug and Alcohol Dependence 48 167
Cohen, P. J. 2002 Untreated addiction imposes an ethical bar to recruiting addicts for non-therapeutic studies of addictive drugs Journal of Law, Medicine & Ethics 30 73
Cohen, R. S. 1998 The Love Drug: Marching to the Beat of Ecstasy New York Haworth Medical Press
Collins, D. Lapsley, H. 2007 The Avoidable Costs of Alcohol Abuse in Australia and the Potential Benefits of Effective Policies to Reduce the Social Costs of Alcohol Canberra Department of Health and Ageing, Commonwealth of Australia
Collins, D. Lapsley, H. 2008 The Costs of Tobacco, Alcohol and Illicit Drug Use to Australian Society in 2004/05. National Drug Strategy Monograph No. 64 Canberra Department of Health and Ageing, Commonwealth of Australia
Collins, F. 1999 Medical and societal consequences of the Human Genome Project New England Journal of Medicine 341 28
Collins, F. 2003 A vision for the future of genomics research Nature 433 835
Comer, S. D. Sullivan, M. A. Yu, E. 2006 Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial Archives of General Psychiatry 63 210
Condit, C. Parrott, R. Harris, T. 2006 Laypeople and behavioural genetics E. Parens A. R. Chapman N. Press Wrestling with Behavioral Genetics: Science, Ethics and Public Conversation 286 Baltimore, MD Johns Hopkins University Press
Conrad, P. 1992 Medicalization and social control Annual Review of Sociology 18 209
Contreras, M. Ceric, F. Torrealba, F. 2007 Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium Science 318 655
Cook, P. J. 2007 Paying the Tab: The Economics of Alcohol Policy Princeton, NJ Princeton University Press
Cornuz, J. Zwahlen, S. Jungi, W. F. 2008 A vaccine against nicotine for smoking cessation: a randomized controlled trial PLoS ONE 3 e2547
Cosgrove, K. P. 2010 Imaging receptor changes in human drug abusers D. W. Self J. K. Staley Gottschalk Behavioral Neuroscience of Drug Addiction 199 Berlin Springer
Courtwright, D. T. 1982 Dark Paradise: Opiate Addiction in America Before 1940 Cambridge, MA Harvard University Press
Courtwright, D. T. 2001 Forces of Habit: Drugs and the Making of the Modern World Cambridge, MA Harvard University Press
Cousins, M. S. Roberts, D. C. de Wit, H. 2002 GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings Drug and Alcohol Dependence 65 209
Cox, W. M. Hogan, L. M. Kristian, M. R. 2002 Alcohol attentional bias as a predictor of alcohol abusers' treatment outcome Drug and Alcohol Dependence 68 237
Craig, A. D. 2002 How do you feel? Interoception: the sense of the physiological condition of the body Nature Reviews. Neuroscience 3 655
Crick, F. 1995 The Astonishing Hypothesis: The Scientific Search for the Soul New York Simon & Schuster
Cunningham, M. G. Bhattacharyya, S. Benes, F. M. 2002 Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence Journal of Comparative Neurology 453 116
Curran, H. V. 1991 Benzodiazepines, memory and mood: a review Psychopharmacology 105 1
Curran, H. V. Kleckham, J. Bearn, J. 2001 Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: a dose-response study Psychopharmacology 154 153
Dackis, C. Kampman, K. Lynch, K. 2004 A double-blind, placebo-controlled trial of modafinil in cocaine dependence Neuropsychopharmacology 29 S72
Dackis, C. O'Brien, C. 2005 Neurobiology of addiction: treatment and public policy ramifications Nature Neuroscience 8 1431
Daglish, M. R. Weinstein, A. Malizia, A. L. 2001 Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects American Journal of Psychiatry 158 1680
Daglish, M. R. Williams, T. M. Wilson, S. 2008 Brain dopamine response in human opioid addiction British Journal of Psychiatry 193 65
Dalrymple, T. 2006 Romancing Opiates: Pharmacological Lies and the Addiction Bureaucracy New York Encounter Books
Damasio, A. R. 1999 The Feeling of What Happens: Body and Emotion in the Making of Consciousness New York Harcourt Brace
Damasio, A. R. Grabowski, T. J. Bechara, A. 2000 Subcortical and cortical brain activity during the feeling of self-generated emotions Nature Neuroscience 3 1049
Daniel, M. Martin, A. D. Carter, J. 1992 Opiate receptor blockade by naltrexone and mood state after acute physical activity British Journal of Sports Medicine 26 111
Darke, S. Hall, W. 2003 Heroin overdose: research and evidence-based intervention Journal of Urban Health 80 189
Darke, S. Ross, J. 2002 Suicide among heroin users: rates, risk factors and methods Addiction 97 1383
Darke, S. Zador, D. 1996 Fatal heroin ‘overdose’: a review Addiction 91 1765
Davies, J. B. 1997 The Myth of Addiction Amsterdam Harwood Academic
De Quincey, T. 1900 Confessions of an Opium Eater. Literary Reminiscences New York D. Appleton
Dean, A. J. Saunders, J. B. Jones, R. T. 2006 Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence Journal of Psychiatry and Neuroscience 31 38
Degenhardt, L. Bucello, C. Mathers, B. 2011 Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies Addiction 106 32
Demyttenaere, K. Bruffaerts, R. Posada-Villa, J. 2004 Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys Journal of the American Medical Association 291 2581
Devlin, M. J. 2007 Is there a place for obesity in DSM-V? International Journal of Eating Disorders 40 S83
Dewey, J. 1990 Logic: The Theory of Inquiry Carbondale Southern Illinois University Press
Di Chiara, G. 1998 A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use Journal of Psychopharmacology 12 54
Dieckmann, G. Schneider, H. 1978 Influence of stereotactic hypothalamotomy on alcohol and drug addiction Applied Neurophysiology 41 93
Diefenbach, G. J. Diefenbach, D. Baumeister, A. 1999 Portrayal of lobotomy in the popular press: 1935–1960 Journal for the History of the Neurosciences 8 60
Dietrich, S. Matschinger, H. Angermeyer, M. 2006 The relationship between biogenetic causal explanations and social distance toward people with mental disorders: results from a population survey in Germany International Journal of Social Psychiatry 52 166
Digiusto, E. Shakeshaft, A. Ritter, A. 2004 Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) Addiction 99 450
Dolan, K. 1999 The Epidemiology of Hepatitis C Infection in Prison Populations Sydney National Drug and Alcohol Research Centre, UNSW
Dolan, K. Kite, B. Black, E. 2006 HIV in prison in low-income and middle-income countries The Lancet Infectious Diseases 7 32
Dolan, K. Wodak, A. Hall, W. 1996 HIV risk behaviour of injecting drug users before, during and after imprisonment in New South Wales Addictive Research 4 151
Dole, V. P. Nyswander, M. 1965 A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride Journal of the American Medical Association 193 646
Domes, G. Heinrichs, M. Glascher, J. 2007 Oxytocin attenuates amygdala responses to emotional faces regardless of valence Biological Psychiatry 62 1187
Domes, G. Heinrichs, M. Michel, A. 2007 Oxytocin improves “mind-reading” in humans Biological Psychiatry 61 731
Donnelly, N. Hall, W. Christie, P. 1995 The effects of partial decriminalisation on cannabis use in South Australia, 1985 to 1993 Australian Journal of Public Health 19 281
Doran, C. M. Hall, W. Shakeshaft, A. P. 2010 Alcohol policy reform in Australia: what can we learn from the evidence? The Medical Journal of Australia 192 468
Doyle, C. 2004
Drevets, W. C. Gautier, C. Price, J. C. 2001 Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria Biological Psychiatry 49 81
Dumit, J. 2004 Picturing Personhood: Brain Scans and Biomedical Identity Princeton, NJ Princeton University Press
Dunn, L. B. Jeste, D. V. 2001 Enhancing informed consent for research and treatment Neuropsychopharmacology 24 595
Dunn, L. B. Nowrangi, M. A. Palmer, B. W. 2006 Assessing decisional capacity for clinical research or treatment: a review of instruments American Journal of Psychiatry 163 1323
Dworkin, G. 1972 Paternalism Monist 56 64
Ebbets, J. 1994 Applicability of the CIWA-A scale. Clinical Institute Withdrawal Assessment for Alcohol Journal of Nursing Care Quality 8 ix
Economic and Social Research Council 2005 Research Ethics Framework (REF) Swindon, UK Economic and Social Research Council
Eigsti, I. M. Zayas, V. Mischel, W. 2006 Predicting cognitive control from preschool to late adolescence and young adulthood Psychological Science 17 478
Elliott, C. 2002 Who holds the leash? American Journal of Bioethics 2 48
Elliott, C. 2003 Better Than Well: American Medicine Meets the American Dream New York W.W. Norton
Elliott, R. Csete, J. Wood, E. 2005 Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy Health and Human Rights 8 104
Elster, J. Skog, O. -J. 1999 Getting Hooked: Rationality and Addiction Cambridge, UK Cambridge University Press
EMCDDA 2006 Annual Report on the State of the Drugs Problem in the European Union, 2006 Belgium European Monitoring Centre for Drugs and Drug Addiction
Epstein, D. H. Preston, K. L. Stewart, J. 2006 Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure Psychopharmacology 189 1
Ersche, K. Fletcher, P. C. Lewis, S. J. 2005 Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals Psychopharmacology 180 612
Ersche, K. Roiser, J. Lucas, M. 2011 Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment Psychopharmacology 214 779
Eskapa, R. D. 2008 The Cure for Alcoholism: Drink Your Way Sober Without Willpower, Abstinence, or Discomfort. The Sinclair Method, a Medically Proven Cure for Alcoholism Dallas, TX BenBella Books
Evans, J. P. Meslin, E. M. Marteau, T. M. 2011 Deflating the genomic bubble Science 331 861
Everitt, B. J. Robbins, T. W. 2005 Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nature Neuroscience 8 1481
Ezzati, M. Lopez, A. Rogers, A. 2004 Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors Geneva World Health Organization
Faden, R. R. Beauchamp, T. L. King, N. M. 1986 A History and Theory of Informed Consent New York Oxford University Press
Faillace, L. Flamer, R. Imber, S. 1972 Giving alcohol to alcoholics Quarterly Journal of Studies on Alcohol 33 85
Farabee, D. Leukefeld, C. G. 2001 Recovery and the criminal justice system M. T. Frank C. G. Leukefeld J. J. Platt Relapse and Recovery in Addiction 40 London Yale University Press
Farah, M. J. 2002 Emerging ethical issues in neuroscience Nature Neuroscience 5 1123
Farah, M. J. 2005 Neuroethics: the practical and the philosophical Trends in Cognitive Sciences 9 34
Farah, M. J. 2010 Neuroethics: An Introduction with Readings Cambridge, MA MIT Press
Farah, M. J. Illes, J. Cook-Deegan, R. 2004 Neurocognitive enhancement: what can we do and what should we do? Nature Reviews. Neuroscience 5 421
Farah, M. J. Wolpe, P. R. 2004 Monitoring and manipulating brain function: new neuroscience technologies and their ethical implications Hastings Center Report 34 35
FDA 2009
FDA 2010
Featherby, T. van den Buuse, M. Lubman, D. I. 2008 Persistent downregulation of hippocampal CREB mRNA parallels a Y-maze deficit in adolescent rats following semi-chronic amphetamine administration British Journal of Pharmacology 154 417
Fehr, C. Yakushev, I. Hohmann, N. 2008 Association of low striatal dopamine D2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse American Journal of Psychiatry 165 507
Feil, J. Sheppard, D. Fitzgerald, P. B. 2010 Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control Neuroscience & Biobehavioral Reviews 35 248
Feinberg, J. 1971 Legal paternalism Canadian Journal of Philosophy 1 105
Feinberg, J. 1980 Rights, Justice, and the Bounds of Liberty: Essays in Social Philosophy Princeton, N.J Princeton University Press
Feltenstein, M. W. See, R. E. 2008 The neurocircuitry of addiction: an overview British Journal of Pharmacology 154 261
Fenton, Z. 2003 Project Prevention: cash for birth control, a solution or a violation of rights The Journal of Law in Society 5 199
Festinger, D. S. Dugosh, K. L. Croft, J. R. 2010 Corrected feedback: a procedure to enhance recall of informed consent to research among substance abusing offenders Ethics & Behavior 20 387
Festinger, D. S. Marlowe, D. B. Croft, J. R. 2009 Monetary incentives improve recall of research consent information: it pays to remember Experimental and Clinical Psychopharmacology 17 99
Festinger, D. S. Ratanadilok, K. Marlowe, D. B. 2007 Neuropsychological functioning and recall of research consent information among drug court clients Ethics & Behavior 17 163
Fillmore, M. T. 2003 Drug abuse as a problem of impaired control: current approaches and findings Behavioural and Cognitive Neuroscience Reviews 2 179
Fingarette, H. 1988 Heavy Drinking: The Myth of Alcoholism as a Disease Berkley, CA University of California Press
Finnigan, F. Hammerslay, R. 1992 The effect of alcohol on performance A. P. Smith D. M. Jones Handbook of Human Performance, Health and Performance 2 73 London Academic Press
Fiscella, K. Moore, A. Engerman, J. 2005 Management of opiate detoxification in jails Journal of Addictive Diseases 24 61
Fisch, G. S. 2007 Animal models and human neuropsychiatric disorders Behavior Genetics V37 1
Fischer, H. Tillfors, M. Furmark, T. 2001 Dispositional pessimism and amygdala activity: a PET study in healthy volunteers Neuroreport 12 1635
Fischer, H. Wik, G. Fredrikson, M. 1997 Extraversion, neuroticism and brain function: a PET study of personality Personality and Individual Differences 23 345
Fisher, C. B. Oransky, M. Mahadevan, M. 2008 Marginalized populations and drug addiction research: realism, mistrust, and misconception IRB; A Review of Human Subjects Research 30 1
Fishman, M. 2008 Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone Addiction 103 1399
Fitzgerald, J. Hamilton, M. 1996 The consequences of knowing: ethical and legal liabilities in illicit drug research Social Science and Medicine 43 1591
Flowers, C. R. Veenstra, D. 2004 The role of cost-effectiveness analysis in the era of pharmacogenomics Pharmacoeconomics 22 481
Foddy, B. Savulescu, J. 2006 Addiction and autonomy: can addicted people consent to the prescription of their drug of addiction? Bioethics 20 1
Foltz, E. L. White, L. E., Jr. 1962 Pain “relief” by frontal cingulumotomy Journal of Neurosurgery 19 89
Forman, R. F. Bovasso, G. Woody, G. 2002 Staff beliefs about drug abuse clinical trials Journal of Substance Abuse Treatment 23 55
Foster, K. R. Wolpe, P. R. Caplan, A. L. 2003 Bioethics & the brain IEEE Spectrum 40 34
Fox, R. G. 1992 The compulsion of voluntary treatment in sentencing Criminal Law Journal 16 37
Frank, M. J. Samanta, J. Moustafa, A. A. 2007 Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism Science 318 1309
Franzini, A. Ferroli, P. Leone, M. 2003 Stimulation of the posterior hypothalamus for treatment of chronic intractable cluster headaches: first reported series Neurosurgery 52 1095
Franzini, A. Marras, C. Ferroli, P. 2005 Stimulation of the posterior hypothalamus for medically intractable impulsive and violent behavior Stereotactic and Functional Neurosurgery 83 63
Fry, C. Dwyer, R. 2001 For love or money? An exploratory study of why injecting drug users participate in research Addiction 96 1319
Fry, C. Hall, W. Ritter, A. 2006 The ethics of paying drug users who participate in research: a review and practical recommendations Journal of Empirical Research on Human Research Ethics 1 21
Fukuyama, F. 2002 Our Posthuman Future: Consequences of the Biotechnology Revolution London Profile Books
Fureman, I. Meyers, K. McLellan, A. T. 1997 Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV vaccine efficacy trials AIDS Education and Prevention 9 330
Gabriels, L. Cosyns, P. Nuttin, B. 2003 Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: psychopathological and neuropsychological outcome in three cases Acta Psychiatrica Scandinavica 107 275
Gahlinger, P. M. 2004 Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine American Family Physician 69 2619
Gallinat, J. Bauer, M. Heinz, A. 2008 Genes and neuroimaging: advances in psychiatric research Neurodegenerative Disease 5 277
Gao, G. Wang, X. He, S. 2003 Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery Stereotactic and Functional Neurosurgery 81 96
Garavan, H. Lingford-Hughes, A. Jones, T. 2007 Neuroimaging D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 285 London Academic Press
Garavan, H. Stout, J. C. 2005 Neurocognitive insights into substance abuse Trends in Cognitive Sciences 9 195
Garbutt, J. C. Kranzler, H. R. O'Malley, S. S. 2005 Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence JAMA 293 1617
Gartner, C. E. Barendregt, J. J. Hall, W. 2009 Multiple genetic tests for susceptibility to smoking do not outperform simple family history Addiction 104 118
Gartner, C. E. Hall, W. Vos, T. 2007 Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study Lancet 369 2010
Gastfriend, D. R. 2011 Intramuscular extended-release naltrexone: current evidence Annals of the New York Academy of Sciences 1216 144
Geppert, C. M. A. Roberts, L. W. 2005 Ethical issues in the use of genetic information in the workplace: a review of recent developments Current Opinion in Psychiatry 18 518
Gerstein, D. R. Harwood, H. J. 1990 Treating Drug Problems (Volume 1). A Study of Effectiveness and Financing of Public and Private Drug Treatment Systems Washington, DC Institute of Medicine, National Academy Press
Geyer, M. A. Markou, A. 1995 Animal models of psychiatric disorders F. E. Bloom D.J. Kupfer Psychopharmacology: The Fourth Generation of Progress 787 New York Raven
Gibson, A. E. Degenhardt, L. J. 2007 Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records Drug and Alcohol Review 26 405
Gibson, A. E. Degenhardt, L. J. Hall, W. 2007 Opioid overdose deaths can occur in patients with naltrexone implants Medical Journal of Australia 186 152
Gieringer, D. H. 2003 The acceptance of medicinal marijuana in the US Journal of Cannabis Therapeutics 3 53
Gillett, G. 2008 Subjectivity and Being Somebody: Human Identity and Neuroethics Exeter, UK Imprint Academic
Gilmore, N. 1995 Drug use and human rights: privacy, vulnerability, disability and human rights infringements Journal of Contemporary Health Law and Policy 12 355
Giordano, J. Gordijn, B. 2010 Scientific and Philosophical Perspectives in Neuroethics New York Cambridge University Press
Gisquet, E. 2008 Cerebral implants and Parkinson's disease: a unique form of biographical disruption? Social Science and Medicine 67 1847
Glannon, W. 2006 Bioethics and the Brain New York Oxford University Press
Glannon, W. 2006 Psychopharmacology and memory Journal of Medical Ethics 32 74
Glick, S. D. Maisonneuve, I. M. Kitchen, B. A. 2002 Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration European Journal of Pharmacology 438 99
Goff, P. 2005
Gogtay, N. Giedd, J. N. Lusk, L. 2004 Dynamic mapping of human cortical development during childhood through early adulthood Proceedings of the National Academy of Sciences of the United States of America 101 8174
Gold, C. G. Cullen, D. J. Gonzales, S. 1999 Rapid opioid detoxification during general anesthesia: a review of 20 patients Anesthesiology 91 1639
Gold, L. H. Koob, G. F. 1989 MDMA produces stimulant-like conditioned locomotor activity Psychopharmacology 99 352
Goldman, D. Oroszi, G. Ducci, F. 2005 The genetics of addictions: uncovering the genes Nature Reviews. Genetics 6 521
Goldstein, A. Herrera, J. 1995 Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up Drug and Alcohol Dependence 40 139
Goldstein, A. Kalant, H. 1990 Drug policy: striking the right balance Science 249 1513
Goldstein, R. Z. Alia-Klein, N. Tomasi, D. 2007 Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? American Journal of Psychiatry 164 43
Goldstein, R. Z. Craig, A. D. Bechara, A. 2009 The neurocircuitry of impaired insight in drug addiction Trends in Cognitive Sciences 13 372
Goldstein, R. Z. Volkow, N. D. 2002 Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex American Journal of Psychiatry 159 1642
Gonzalez, G. Oliveto, A. Kosten, T. R. 2004 Combating opiate dependence: a comparison among the available pharmacological options Expert Opinion on Pharmacotherapy 5 713
Goodman, A. 2008 Neurobiology of addiction: an integrative review Biochemical Pharmacology 75 266
Gorelick, D. Pickens, R. W. Benkovsky, F. O. 1999 Clinical research in substance abuse: human subjects issues H. A. Pinchus J. A. Lieberman S. Ferris Ethics in Psychiatric Research: A Resource Manual for Human Subjects' Protection 177 Washington, DC American Psychiatric Association
Gostin, L. O. 1993 Compulsory treatment for drug-dependent persons: justifications for a public health approach to drug dependency R. Bayer G. M. Oppenheimer Confronting Drug Policy: Illicit Drugs in a Free Society 561 Cambridge, UK Cambridge University Press
Gostin, L. O. 2001 Beyond moral claims: a human rights approach in mental health Cambridge Quarterly of Healthcare Ethics 10 264
Gostin, L. O. Mann, J. M. 1999 Toward a development of a human rights impact assessment for the formulation and evaluation of public health policies J. M. Mann Health and Human Rights: A Reader 54 London Routledge
Goudriaan, A. Grekin, E. R. Sher, K. J. 2008 The predictive value of neurocognitive decision-making for heavy alcohol use in a longitudinal, prospective study European Neuropsychopharmacology 18 S69
Goudriaan, A. Oosterlaan, J. De Beurs, E. 2008 The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers Psychological Medicine 38 41
Gowing, L. Ali, R. White, J. 2006
Gowing, L. Ali, R. White, J. M. 2009
Granfield, R. Cloud, W. 1996 The elephant that no one sees: natural recovery among middle-class addicts Journal of Drug Issues 26 45
Grant, J. E. Brewer, J. A. Potenza, M. N. 2006 The neurobiology of substance and behavioral addictions CNS Spectrums 11 924
Grant, J. E. Odlaug, B. L. Potenza, M. N. 2010 Nalmefene in the treatment of pathological gambling: multicentre, double-blind, placebo-controlled study British Journal of Psychiatry 197 330
Grant, S. Contoreggi, C. London, E. D. 2000 Drug abusers show impaired performance in a laboratory test of decision making Neuropsychologia 38 1180
Greely, H. 2001 Genotype discrimination: the complex case for some legislative protection University of Pennsylvania Law Review 149 1438
Greely, H. Sahakian, B. Harris, J. 2008 Towards responsible use of cognitive-enhancing drugs by the healthy Nature 456 702
Greenberg, B. D. Malone, D. A. Friehs, G. M. 2006 Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder Neuropsychopharmacology 31 2384
Greenway, F. L. Fujioka, K. Plodkowski, R. A. 2010 Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Lancet 376 595
Grisso, T. Applebaum, P. S. 1998 Assessing Competence to Consent to Treatment: A Guide for Physicians and Other Health Professionals New York Oxford University Press
Guichard, A. Lert, F. Brodeur, J. M. 2007 Buprenorphine substitution treatment in France: drug users' views of the doctor–user relationship Social Science & Medicine 64 2578
Gundle, K. R. Dingel, M. J. Koenig, B. A. 2010 ‘To prove this is the industry's best hope’: big tobacco's support of research on the genetics of nicotine addiction Addiction 105 974
Haga, S. B. Khoury, M. J. Burke, W. 2003 Genomic profiling to promote a healthy lifestyle: not ready for prime time Nature Genetics 34 347
Hall, L. L. 1996 The human implications of psychiatric genetics L. L. Hall Genetics and Mental Illness: Evolving Issues for Research and Society 157 New York, NY Plenum Press
Hall, M. A. Rich, S. S. 2000 Laws restricting health insurers' use of genetic information: impact on genetic discrimination American Journal of Human Genetics 66 293
Hall, W. 1997 The recent Australian debate about the prohibition on cannabis use Addiction 92 1109
Hall, W. 1997 The role of legal coercion in the treatment of offenders with alcohol and heroin problems Australian and New Zealand Journal of Criminology 30 103
Hall, W. 2000 UROD: an antipodean therapeutic enthusiasm Addiction 95 1765
Hall, W. 2002 The prospects for immunotherapy in smoking cessation Lancet 360 1089
Hall, W. 2002 Taking Darwin seriously: more than telling “just so” stories Addiction 97 472
Hall, W. 2004 Feeling ‘better than well’: can our experiences with psychoactive drugs help us to meet the challenges of novel neuroenhancement methods? EMBO Reports 5 1105
Hall, W. 2005 British drinking: a suitable case for treatment? British Medical Journal 331 527
Hall, W. 2005 Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases? PLoS Medicine 2
Hall, W. 2006 The regulatory challenges in engineering a safer tipple Journal of Psychopharmacology 20 321
Hall, W. 2006 Stereotactic neurosurgical treatment of addiction: minimising the chances of another ‘great and desperate cure’ Addiction 101 1
Hall, W. 2007 A research agenda for assessing the potential contribution of genomic medicine to tobacco control Tobacco Control 16 53
Hall, W. 2008 The contribution of research to the development of a national cannabis policy in Australia Addiction 103 712
Hall, W. Capps, B. Carter, A. 2008 The use of depot naltrexone under legal coercion: the case for caution Addiction 103 1922
Hall, W. Carter, L. 2004 Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence Journal of Medical Ethics 30 337
Hall, W. Carter, L. Morley, K. I. 2004 Neuroscience research on the addictions: a prospectus for future ethical and policy analysis Addictive Behaviors 29 1481
Hall, W. Degenhardt, L. 2009 Adverse health effects of non-medical cannabis use Lancet 374 1383
Hall, W. Doran, C. Degenhardt, L. 2006 Illicit opiate use D. T. Jamison Disease Control Priorities in Developing Countries 907 New York Oxford University Press
Hall, W. Gartner, C. E. Carter, A. 2008 The genetics of nicotine addiction liability: ethical and social policy implications Addiction 103 350
Hall, W. Lucke, J. 2010 The enhancement use of neuropharmaceuticals: more scepticism and caution needed Addiction 105 2041
Hall, W. Lucke, J. 2010 Legally coerced treatment for drug using offenders: ethical and policy issues Crime and Justice Bulletin 144 1
Hall, W. Madden, P. Lynskey, M. 2002 The genetics of tobacco use: methods, findings and policy implications Tobacco Control 11 119
Hall, W. Mattick, R. P. 2000 Is ultra-rapid opioid detoxification a viable option in the treatment of opioid dependence? CNS Drugs 14 251
Hall, W. Morley, K. I. Lucke, J. 2004 The prediction of disease risk in genomic medicine: scientific prospects and implications for public policy and ethics EMBO Reports 5 S22
Hall, W. Pacula, R. L. 2003 Cannabis Use and Dependence: Public Health and Public Policy Cambridge Cambridge University Press
Hall, W. Room, R. Bondy, S. 1999 Comparing the health and psychological risks of alcohol, cannabis, nicotine and opiate use H. Kalant W. Corrigal W. Hall The Health Effects of Cannabis 475 Toronto Centre for Addiction and Mental Health
Hall, W. Sannibale, C. 1996 Are there two types of alcoholism? Lancet 348 1258
Hamani, C. McAndrews, M. P. Cohn, M. 2008 Memory enhancement induced by hypothalamic/fornix deep brain stimulation Annals of Neurology 63 119
Hamilton, R. J. Olmedo, R. E. Shah, S. 2002 Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets Academic Emergency Medicine 9 63
Hando, J. Darke, S. 1998 NSW Drug Trends 1997. Findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre Technical Report 56 Sydney National Drug and Alcohol Research Centre, University of New South Wales
Harrison, K. Vlahov, D. Jones, K. 1995 Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 10 386
Harwood, H. J. Myers, T. G. 2004 New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions Washington, DC National Academies Press
Hasin, D. S. 1994 Treatment/self-help for alcohol-related problems: relationship to social pressure and alcohol dependence Journal of Studies on Alcohol 55 660
Hasman, A. Holm, S. 2004 Nicotine conjugate vaccine: is there a right to a smoking future? Journal of Medical Ethics 30 344
Hauser, M. D. 2006 Moral Minds: How Nature Designed our Universal Sense of Right and Wrong New York Ecco
Hawkins, J. D. Catalano, R. F. Miller, J. Y. 1992 Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention Psychological Bulletin 112 64
Hazelton, L. D. Sterns, G. L. Chisholm, T. 2003 Decision-making capacity and alcohol abuse: clinical and ethical considerations in personal care choices General Hospital Psychiatry 25 130
Healy, D. 2002 The Creation of Psychopharmacology Cambridge, MA Harvard University Press
Healy, D. 2004 Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression New York New York University Press
Heinz, A. Reimold, M. Wrase, J. 2005 Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil Archives of General Psychiatry 62 57
Heinze, H. J. Heldmann, M. Voges, J. 2009 Counteracting incentive sensitization in severe alcohol dependence using deep brain stimulation of the nucleus accumbens: clinical and basic science aspects Frontiers in Human Neuroscience 3 22
Heinzerling, K. G. Swanson, A.-N. Kim, S. 2010 Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence Drug and Alcohol Dependence 109 20
Hejazi, N. S. 2007 Pharmacogenetic aspects of addictive behaviors Dialogues in Clinical Neuroscience 9 447
Helfand, W. H. 1996 Selling addiction cures Transactions and Studies of the College of Physicians of Philadelphia 18 85
Herz, A. 1997 Endogenous opioid systems and alcohol addiction Psychopharmacology 129 99
Hester, R. Garavan, H. 2004 Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity Journal of Neuroscience 24 11017
Heyman, G. 2009 Addiction: A Disorder of Choice Cambridge, MA Harvard University Press
Higgins, S. T. 2006 Extending contingency management to the treatment of methamphetamine use disorders American Journal of Psychiatry 163 1870
Higgins, S. T. Delaney, D. D. Budney, A. J. 1991 A behavioral approach to achieving initial cocaine abstinence American Journal of Psychiatry 148 1218
Higgins, S. T. Petry, N. M. 1999 Contingency management. Incentives for sobriety Alcohol Research and Health 23 122
Hill, E. M. Newlin, D. B. 2002 Evolutionary approaches to addiction: introduction Addiction 97 375
Ho, M. K. Goldman, D. Heinz, A. 2010 Breaking barriers in the genomics and pharmacogenetics of drug addiction Clinical Pharmacology and Therapeutics 88 779
Hoff, N. Evers-Casey, S. Weibel, S. 2005 Impact of genetic risk information on smokers' motivation to quit. RP-062, S16 11th Annual Meeting of the Society for Research on Nicotine and Tobacco Prague Czech Republic
Holden, C. 2001 ‘Behavioral’addictions: do they exist? Science 294 980
Holtzman, N. A. Marteau, T. M. 2000 Will genetics revolutionize medicine? New England Journal of Medicine 343 141
Horka-Ruiz, J. 2000 Preventing the birth of drug-addicted babies through contract: an examination of the CRACK Organization William and Mary Journal of Women and the Law 7 473
Hotopf, M. 2005 The assessment of mental capacity Clinical Medicine 5 580
Hotze, T. D. Shah, K. Anderson, E. E. 2011 “Doctor, would you prescribe a pill to help me. . .?” A national survey of physicians on using medicine for human enhancement The American Journal of Bioethics 11 3
Hubbard, R. L. Collins, J. J. Rachal, J. H. 1988 The criminal justice client in drug abuse treatment C. Leukefeld F. M. Tims Compulsory Treatment of Drug Abuse: Research and Clinical Practice Rockville, MD National Institute of Drug Abuse
Hughes, J. R. 2009 Smokers' beliefs about the inability to stop smoking Addictive Behaviors 34 1005
Hulse, G. K. Arnold-Reed, D. E. O'Neil, G. 2004 Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants Addiction Biology 9 67
Hulse, G. K. English, D. R. Milne, E. 1999 The quantification of mortality resulting from the regular use of illicit opiates Addiction 94 221
Hulse, G. K. Stalenberg, V. McCallum, D. 2005 Histological changes over time around the site of sustained release naltrexone-poly(DL-lactide) implants in humans Journal of Controlled Release 108 43
Hume, D. 1978 A Treatise of Human Nature Oxford Oxford University Press
Husak, D. N. 1992 Drugs and Rights Cambridge, England Cambridge University Press
Hutcheson, D. M. Everitt, B. J. Robbins, T. W. 2001 The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nature Neuroscience 4 943
Hutchison, K. E. 2010 Substance use disorders: realizing the promise of pharmacogenomics and personalized medicine Annual Review of Clinical Psychology 6 577
Huxley, A. 1954 The Doors of Perception New York Harper
Hyman, S. E. 2005 Addiction: a disease of learning and memory American Journal of Psychiatry 162 1414
Hyman, S. E. 2007 The neurobiology of addiction: implications for voluntary control of behavior American Journal of Bioethics 7 8
Hyman, S. E. Malenka, R. C. Nestler, E. J. 2006 Neural mechanisms of addiction: the role of reward-related learning and memory Annual Review of Neuroscience 29 565
Illes, J. 2003 Neuroethics in a new era of neuroimaging American Journal of Neuroradiology 24 1739
Illes, J. 2006 Neuroethics: Defining the Issues in Theory, Practice, and Policy Oxford Oxford University Press
Illes, J. 2007 Empirical neuroethics. Can brain imaging visualize human thought? Why is neuroethics interested in such a possibility? EMBO Reports 8 S57
Illes, J. Kirschen, M. P. Edwards, E. 2006 Ethics. Incidental findings in brain imaging research Science 311 783
Illes, J. Kirschen, M. P. Karetsky, K. 2004 Discovery and disclosure of incidental findings in neuroimaging research Journal of Magnetic Resonance Imaging 20 743
Illes, J. Racine, E. 2005 Imaging or imagining? A neuroethics challenge informed by genetics American Journal of Bioethics 5 5
Illes, J. Rosen, A. Greicius, M. 2007 Prospects for prediction: ethics analysis of neuroimaging in Alzheimer's disease Annals of the New York Academy of Sciences 1097 278
Illes, J. Rosen, A. C. Huang, L. 2004 Ethical consideration of incidental findings on adult brain MRI in research Neurology 62 888
Insel, T. R. 2009 Translating scientific opportunity into public health impact: a strategic plan for research on mental illness Archives of General Psychiatry 66 128
International Federation of Red Cross and Red Crescent Societies and Francois-Xavier Bagnoud Center for Health and Human Rights 1999 Human rights: an introduction J. M. Mann Health and Human Rights: A Reader 21 London Routledge
Ioannidis, J. P. 2011
Ito, H. Matsuo, K. Wakai, K. 2006 An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan Preventive Medicine 42 102
Iversen, L. 2002 The Science of Marijuana Oxford Oxford University Press
Iversen, S. Iversen, L. 2007 Dopamine: 50 years in perspective Trends in Neurosciences 30 188
Iverson, L. Morris, K. Nutt, D. 2007 Pharmacology and treatments D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 169 London Academic Press
Jayaram-Lindstrom, N. Hammarberg, A. Beck, O. 2008 Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial American Journal of Psychiatry 165 1442
Jentsch, J. D. Taylor, J. R. 1999 Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli Psychopharmacology 146 373
Jeste, D. V. Saks, E. 2006 Decisional capacity in mental illness and substance use disorders: empirical database and policy implications Behavioral Sciences and the Law 24 607
John, U. Meyer, C. Hapke, U. 2004 Nicotine dependence, quit attempts, and quitting among smokers in a regional population sample from a country with a high prevalence of tobacco smoking Preventive Medicine 38 350
Johnson, B. A. Rosenthal, N. Capece, J. A. 2007 Topiramate for treating alcohol dependence: a randomized controlled trial Journal of the American Medical Association 298 1641
Joint Committee of the American Bar Association and the American Medical Association on Narcotic Drugs 1961 Drug Addiction: Crime or Disease Bloomington Indiana University Press
Joly, Y. Braker, M. Le Huynh, M. 2010 Genetic discrimination in private insurance: global perspectives New Genetics and Society 29 351
Jonsen, A. R. 1998 The Birth of Bioethics New York Oxford University Press
Jorenby, D. E. Leischow, S. J. Nides, M. A. 1999 A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation New England Journal of Medicine 340 685
Jupp, B. Lawrence, A. J. 2009 New horizons for therapeutics in drug and alcohol abuse Pharmacology and Therapeutics 125 138
Jurgens, R. Betteridge, G. 2005 Prisoners who inject drugs: public health and human rights imperatives Health and Human Rights 8 46
Kagan, J. 2006 An Argument for Mind London Yale University Press
Kalant, H. 2010 What neurobiology cannot tell us about addiction Addiction 105 780
Kalivas, P. W. Volkow, N. D. 2005 The neural basis of addiction: a pathology of motivation and choice American Journal of Psychiatry 162 1403
Kampman, K. M. Pettinati, H. Lynch, K. G. 2004 A pilot trial of topiramate for the treatment of cocaine dependence Drug and Alcohol Dependence 75 233
Kampman, K. M. Volpicelli, J. R. Mulvaney, F. 2001 Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity Drug and Alcohol Dependence 63 69
Kanaka, T. S. Balasubramaniam, V. 1978 Stereotactic cingulumotomy for drug addiction Applied Neurophysiology 41 86
Kandel, E. 2006 In Search of Memory: The Emergence of a New Science of Mind New York W.W. Norton
Kant, I. 1996 The Metaphysics of Morals New York Cambridge University Press
Kantak, K. M. 2003 Vaccines against drugs of abuse: a viable treatment option? Drugs 63 341
Karila, L. Weinstein, A. Aubin, H. -J. 2010 Pharmacological approaches to methamphetamine dependence: a focused review British Journal of Clinical Pharmacology 69 578
Kariminia, A. Law, M. G. Butler, T. G. 2007 Suicide risk among recently released prisoners in New South Wales, Australia Medical Journal of Australia 187 387
Kass, L. 2002 Life, Liberty and the Defense of Dignity San Francisco, CA Encounter Books
Kauer, J. Malenka, R. C. 2007 Synaptic plasticity and addiction Nature Reviews. Neuroscience 8 844
Keane, H. 2005 Moral frameworks, ethical engagement and harm reduction: commentary on “Ethical challenges and responses in harm reduction research: promoting applied communitarian ethics” by C. L. Fry, C. Treloar and L. Maher Drug and Alcohol Review 24 551
Kelley, A. E. 2004 Memory and addiction: shared neural circuitry and molecular mechanisms Neuron 44 161
Kelley, A. E. Berridge, K. C. 2002 The neuroscience of natural rewards: relevance to addictive drugs Journal of Neuroscience 22 3306
Kelman, H. 1964 Narcotic Withdrawal Syndrome. Suppression of by means of electric convulsive therapy Minnesota Medicine 47 525
Kenney, C. Simpson, R. Hunter, C. 2007 Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders Journal of Neurosurgery 106 621
Kessler, R. C. Berglund, P. M. Demler, O. M. 2005 Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Archives of General Psychiatry 62 593
Khantzian, E. J. 1985 The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence American Journal of Psychiatry 142 1259
Khantzian, E. J. 1997 The self-medication hypothesis of substance use disorders: a reconsideration and recent applications Harvard Review of Psychiatry 4 231
Khoury, M. J. McCabe, L. L. McCabe, E. R. B. 2003 Genomic medicine: population screening in the age of genomic medicine New England Journal of Medicine 348 50
Khoury, M. J. Thrasher, J. F. Burke, W. 2000 Challenges in communicating genetics: a public health approach Genetics in Medicine 2 198
Khoury, M. J. Yang, Q. H. Gwinn, M. 2004 An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions Genetics in Medicine 6 38
Kilts, C. D. Schweitzer, J. B. Quinn, C. K. 2001 Neural activity related to drug craving in cocaine addiction Archives of General Psychiatry 58 334
Kiluk, B. D. Nich, C. Carroll, K. M. 2010 Neurocognitive indicators predict results of an informed-consent quiz among substance-dependent treatment seekers entering a randomized clinical trial Journal of Studies on Alcohol and Drugs 71 704
Kirchmayer, U. Davoli, M. Verster, A. 2003 Naltrexone maintenance treatment for opioid dependence Cochrane Database of Systematic Reviews 2
Kirulis, K. Zacny, J. 1998 Do healthy volunteers increase drug usage after participation in research involving opioids and nitrous oxide? Anesthesiology 89 1222
Kisely, S. 2008 The case for policy reform in cannabis control Canadian Journal of Psychiatry 53 795
Klag, S. O'Callaghan, F. Creed, P. 2005 The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research Substance Use & Misuse 40 1777
Kleber, H. D. Riordan, C. E. 1982 The treatment of narcotic withdrawal: a historical review Journal of Clinical Psychiatry 43 30
Kleiman, M. 1992 Against Excess: Towards a Drug Policy that Works New York Basic Books
Kleinig, J. 1985 Ethical Issues in Psychosurgery London Allen & Unwin
Kleinig, J. 2004 Ethical issues in substance use intervention Substance Use & Misuse 39 369
Klingemann, H. Bergmark, A. 2006 The legitimacy of addiction treatment in a world of smart people Addiction 101 1230
Knapp, C. M. Tozier, L. Pak, A. 2009 Deep brain stimulation of the nucleus accumbens reduces ethanol consumption in rats Pharmacology, Biochemistry & Behavior 92 474
Knight, G. 1969 Chronic depression and drug addiction treated by stereotactic surgery Nursing Times 65 583
Knightly, P. 1979 Suffer the Children: The Story of Thalidomide New York The Viking Press
Kolb, L. Himmelsbach, C. K. 1938 Clinical studies of drug addiction III: a critical review of the withdrawal treatments with method of evaluating abstinence syndromes American Journal of Psychiatry 94 759
Koob, G. F. 1999 Stress, corticotropin-releasing factor, and drug addiction Annals of the New York Academy of Sciences 897 27
Koob, G. F. 2008 A role for brain stress systems in addiction Neuron 59 11
Koob, G. F. Bloom, F. E. 1988 Cellular and molecular mechanisms of drug dependence Science 242 715
Koob, G. F. Kreek, M. J. 2007 Stress, dysregulation of drug reward pathways, and the transition to drug dependence American Journal of Psychiatry 164 1149
Koob, G. F. Le Moal, M. 1997 Drug abuse: hedonic homeostatic dysregulation Science 278 52
Koob, G. F. Le Moal, M. 2005 Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction Nature Neuroscience 8 1442
Koob, G. F. Le Moal, M. 2006 Neurobiology of Addiction New York Academic Press
Koob, G. F. Le Moal, M. 2008 Addiction and the brain antireward system Annual Review of Psychology 59 29
Koob, G. F. Lloyd, G. K. Mason, B. J. 2009 Development of pharmacotherapies for drug addiction: a Rosetta Stone approach Nature Reviews Drug Discovery 8 500
Korf, D. J. 2002 Dutch coffee shops and trends in cannabis use Addictive Behaviors 27 851
Kosfeld, M. Heinrichs, M. Zak, P. J. 2005 Oxytocin increases trust in humans Nature 435 673
Kosten, T. Owens, S. M. 2005 Immunotherapy for the treatment of drug abuse Pharmacology & Therapeutics 108 76
Kosten, T. Rosen, M. Bond, J. 2002 Human therapeutic cocaine vaccine: safety and immunogenicity Vaccine 20 1196
Krack, P. Hariz, M. I. Baunez, C. 2010 Deep brain stimulation: from neurology to psychiatry? Trends in Neurosciences 33 474
Kranzler, H. R. Dolinsky, Z. Kaplan, R. F. 1990 Giving ethanol to alcoholics in a research setting: its effect on compliance with disulfiram treatment British Journal of Addiction 85 119
Kranzler, H. R. Modesto-Lowe, V. Nuwayser, E. S. 1998 Sustained-release naltrexone for alcoholism treatment: a preliminary study Alcoholism, Clinical and Experimental Research 22 1074
Krupitsky, E. Blokhina, E. A. 2010 Long-acting depot formulations of naltrexone for heroin dependence: a review Current Opinion in Psychiatry 23 210
Krupitsky, E. Zvartau, E. Masalov, D. V. 2004 Naltrexone for heroin dependence treatment in St. Petersburg, Russia Journal of Substance Abuse Treatment 26 285
Krupitsky, E. Zvartau, E. Woody, G. 2010 Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available Current Psychiatry Reports 12 448
Kruptisky, E. M. Burakov, A. M. Tsoy, M. V. 2007 Overcoming opioid blockade from depot naltrexone (Prodetoxon®) Addiction 102 1164
Kuehn, B. M. 2009 Studies linking smoking-cessation drug with suicide risk spark concerns JAMA 301 1007
Kuhn, J. Bauer, R. Pohl, S. 2009 Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens European Addiction Research 15 196
Kuhn, J. Lenartz, D. Huff, W. 2007 Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? Journal of Neurology, Neurosurgery and Psychiatry 78 1152
Kunoe, N. Lobmaier, P. Vederhus, J. K. 2009 Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial British Journal of Psychiatry 194 541
Lahti, T. Halme, J. T. Pankakoski, M. 2010 Treatment of pathological gambling with naltrexone pharmacotherapy and brief intervention: a pilot study Psychopharmacology Bulletin 43 35
Lanteri, C. Salomon, L. Torrens, Y. 2008 Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non-dopaminergic mechanism Neuropsychopharmacology 33 1724
LaRowe, S. D. Mardikian, P. Malcolm, R. 2006 Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals The American Journal of Addictions 15 105
Larriviere, D. Williams, M. A. Rizzo, M. 2009 Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee Neurology 73 1406
Laruelle, M. Abi-Dargham, A. van Dyck, C. H. 1995 SPECT imaging of striatal dopamine release after amphetamine challenge Journal of Nuclear Medicine 36 1182
Lawford, B. R. Young, R. M. Noble, E. P. 2000 The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment American Journal of Medical Genetics 96 592
Leader, A. E. Lerman, C. Cappella, J. N. 2010 Nicotine vaccines: will smokers take a shot at quitting? Nicotine and Tobacco Research 12 390
Lee, A. M. Tyndale, R. F. 2006 Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment Journal of Psychopharmacology 20 7
Lerman, C. Berrettini, W. 2003 Elucidating the role of genetic factors in smoking behavior and nicotine dependence American Journal of Medical Genetics 118 48
Lerman, C. Gold, K. Audrain, J. 1997 Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking related cognitions, emotions and behavior change Health Psychology 16 87
Leshner, A. I. 1997 Addiction is a brain disease, and it matters Science 278 45
Leshner, A. I. 2005 It's time to go public with neuroethics American Journal of Bioethics 5 1
Leukefeld, C. G. Tims, F. M. 1988 Compulsory Treatment of Drug Abuse: Research and Clinical Practice Rockville, MD National Institute on Drug Abuse
Levin, F. R. Evans, S. M. Brooks, D. J. 2007 Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo Drug and Alcohol Dependence 87 20
Levy, D. Shabat-Simon, M. Shalev, U. 2007 Repeated electrical stimulation of reward-related brain regions affects cocaine but not “natural” reinforcement Journal of Neuroscience 27 14179
Levy, N. 2006 Addiction, autonomy and ego-depletion: a response to Bennett Foddy and Julian Savulescu Bioethics 20 16
Levy, N. 2006 Autonomy and addiction Canadian Journal of Philosophy 36 427
Levy, N. 2007 Neuroethics: Challenges for the 21st Century Cambridge Cambridge University Press
Levy, N. Clarke, S. 2008 Neuroethics and psychiatry Current Opinion in Psychiatry 21 568
Li, M. D. Burmeister, M. 2009 New insights into the genetics of addiction Nature Reviews. Genetics 10 225
Lim, S. Y. O'Sullivan, S. S. Kotschet, K. 2009 Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease Journal of Clinical Neuroscience 16 1148
Ling, W. Casadonte, P. Bigelow, G. 2010 Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial JAMA 304 1576
Ling, W. Compton, P. 2005 Recent advances in the treatment of opiate addiction Clinical Neuroscience Research 5 161
Lingford-Hughes, A. Nutt, D. 2003 Neurobiology of addiction and implications for treatment British Journal of Psychiatry 182 97
Lingford-Hughes, A. Welch, S. Nutt, D. 2004 Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology Journal of Psychopharmacology 18 293
Lipsman, N. Neimat, J. S. Lozano, A. M. 2007 Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target Neurosurgery 61 1
Liu, H. Y. Jin, J. Tang, J. S. 2008 Chronic deep brain stimulation in the rat nucleus accumbens and its effect on morphine reinforcement Addiction Biology 13 40
Loimer, N. Schmid, R. Lenz, K. 1990 Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone British Journal of Psychiatry 157 748
Loimer, N. Schmid, R. Presslich, O. 1988 Naloxone treatment for opiate withdrawal syndrome British Journal of Psychiatry 153 851
Lu, L. Wang, X. Kosten, T. R. 2009 Stereotactic neurosurgical treatment of drug addiction American Journal of Drug and Alcohol Abuse 35 391
Lubman, D. Hides, L. Yücel, M. 2007 Intervening early to reduce developmentally harmful substance use among youth populations Medical Journal of Australia 187 S22
Lubman, D. Yucel, M. Hall, W. 2007 Substance use and the adolescent brain: a toxic combination? Journal of Psychopharmacology 21 792
Lucke, J. Bell, S. Partridge, B. 2011 Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals EMBO Reports 12 197
Lucke, J. Bell, S. Partridge, B. 2011
Lucke, J. Diedrichs, P. C. Partridge, B. 2009 Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and hormone replacement therapy EMBO Reports 10 108
Lynskey, M. Hall, W. 2001 Attention Deficit Hyperactivity Disorder and substance use disorders: is there a causal link? Addiction 96 815
Lysaught, M. T. 2004 Respect: or, how respect for persons became respect for autonomy Journal of Medicine and Philosophy 29 665
Lyvers, M. Yakimoff, M. 2003 Neuropsychological correlates of opioid dependence and withdrawal Addictive Behaviors 28 605
Maastricht University Medical Center 2009 ® ®
MacCoun, R. 2004 Anticipating unintended consequences of vaccine-like immunotherapies and depot medications of addictive drug use H. J. Harwood T. G. Myers New Treatments for Addiction: Behavioral, Ethical, Legal and Social Questions 241 Washington, DC National Academies Press
MacCoun, R. Reuter, P. 1997 Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate Science 278 47
MacCoun, R. Reuter, P. 2001 Drug-war Heresies: Learning from Other Vices, Times and Places Cambridge Cambridge University Press
Machii, K. Cohen, D. Ramos-Estebanez, C. 2006 Safety of rTMS to non-motor cortical areas in healthy participants and patients Clinical Neurophysiology 117 455
MacIntyre, A. 1985 After Virtue: A Study in Moral Theory London Duckwirth
MacIntyre, A. 1998 A Short History of Ethics: A History of Moral Philosophy from the Homeric Age to the Twentieth Century Notre Dame, IN University of Notre Dame Press
Madden, R. G. 1996 Civil commitment for substance abuse by pregnant women? A view from the front lines Politics and the Life Sciences 15 56
Maddux, J. 1988 Clinical experience with civil commitment C. G. Leukefeld F. M. Tims Compulsory Treatment of Drug Abuse: Research and Clinical Experience 35 Rockville, MD National Institute on Drug Addiction
Maher, B. 2008 Poll results: look who's doping Nature 452 674
Maldonado, R. 1997 Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence Neuroscience and Biobehavioral Reviews 21 91
Mann, J. M. 1997 Medicine and public health, ethics and human rights Hastings Center Report 27 6
Mann, J. M. 1999 Health and human rights J. M. Mann Health and Human Rights: A Reader 7 London Routledge
Mantione, M. van de Brink, W. Schuurman, P. R. 2010 Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report Neurosurgery 66
Marcus, S. 2002 Neuroethics: Mapping the Field San Fransisco The Dana Foundation
Mardikian, P. N. LaRowe, S. D. Hedden, S. 2007 An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 389
Marinelli, M. Piazza, P. V. 2002 Interaction between glucocorticoid hormones, stress and psychostimulant drugs European Journal of Neuroscience 16 387
Marlowe, D. B. 2006 Depot naltrexone in lieu of incarceration: a behavioral analysis of coerced treatment for addicted offenders Journal of Substance Abuse Treatment 31 131
Marteau, T. Ashcroft, R. E. Oliver, A. 2009 Using financial incentives to achieve healthy behaviour British Medical Journal 338 983
Marteau, T. Lerman, C. 2001 Genetic risk and behavioural change British Medical Journal 322 1056
Marteau, T. Munafò, M. R. Aveyard, P. 2010 Trial protocol: using genotype to tailor prescribing of nicotine replacement therapy. A randomised controlled trial assessing impact of communication upon adherence BMC Public Health 10 680
Marteau, T. Richards, D. 1996 The Troubled Helix: Social and Psychological Implications of the New Human Genetics New York Cambridge University Press
Marteau, T. Weinman, J. 2006 Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research Social Science and Medicine 62 1360
Martell, B. A. Orson, F. M. Poling, J. 2009 Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial Archives of General Psychiatry 66 1116
Mathieu, D. 1995 Mandating treatment for pregnant substance abusers: a compromise Politics and the Life Sciences 14 199
Matthew-Simmons, F. Love, S. Ritter, A. 2008 A Review of Australian Public Opinion Surveys on Illicit Drugs Sydney National Drug and Alcohol Research Centre, University of New South Wales
Mattick, R. P. Breen, C. Kimber, J. 2009 Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence Cochrane Database of Systematic Reviews 3
Mattick, R. P. Hall, W. 1996 Are detoxification programmes effective? Lancet 347 97
Mattick, R. P. Kimber, J. Breen, C. 2008 Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence Cochrane Database of Systematic Reviews 2
Mayberg, H. S. Lozano, A. M. Voon, V. 2005 Deep brain stimulation for treatment-resistant depression Neuron 45 651
Mayor, S. 1997 Specialists criticise treatment for heroin addiction British Medical Journal 314 1365
Maze, I. Nestler, E. J. 2011 The epigenetic landscape of addiction Annals of the New York Academy of Sciences 1216 99
McAllister, W. B. 2000 Drug Diplomacy in the Twentieth Century: An International History London Routledge
McBride, C. M. Bepler, G. Lipkus, I. M. 2002 Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income Cancer Epidemiology, Biomarkers and Prevention 11 521
McBride, C. M. Bowen, D. Brody, L. C. 2010 Future health applications of genomics: priorities for communication, behavioral, and social sciences research American Journal of Preventive Medicine 38 556
McCabe, D. P. Castel, A. D. 2008 Seeing is believing: the effect of brain images on judgments of scientific reasoning Cognition 107 343
McClure, S. M. Daw, N. D. Montague, P. R. 2003 A computational substrate for incentive salience Trends in Neurosciences 26 423
McCrady, B. S. Bux, D. A., Jr. 1999 Ethical issues in informed consent with substance abusers Journal of Consulting and Clinical Psychology 67 186
McGee, G. 1999 Pragmatic methods and bioethics G. McGee Pragmatic Bioethics 18 London Vanderbilt University Press
McGregor, I. S. Callaghan, P. D. Hunt, G. E. 2008 From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? British Journal of Pharmacology 154 358
McKeganey, N. Neale, J. Lloyd, C. 2007 Sociology and substance use D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 359 London Academic Press
McLellan, A. T. Lewis, D. C. O'Brien, C. P. 2000 Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation JAMA 284 1689
McLellan, A. T. Skipper, G. S. Campbell, M. 2008 Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States British Medical Journal 337 a2038
McNeely, H. E. Mayberg, H. S. Lozano, A. M. 2008 Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months Journal of Nervous and Mental Disease 196 405
Medvedev, S. V. Anichkov, A. D. Poltakov Iu, I. 2003 Physiological mechanisms of the effectiveness of bilateral stereotactic cingulotomy in treatment of strong psychological dependence in drug addiction Fiziologiia Cheloveka 29 117
Mehta, M. A. Owen, A. M. Sahakian, B. J. 2000 Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain Journal of Neuroscience 20 RC65
Merikangas, K. R. Mehta, R. L. Molnar, B. E. 1998 Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology Addictive Behaviors 23 893
Merikangas, K. R. Risch, N. 2003 Genomic priorities and public health Science 302 599
Merrick, J. C. 1996 Pregnancy and substance abuse: education or mandatory treatment? Politics and the Life Sciences 15 59
Midanik, L. 2006 Biomedicalization of Alcohol Studies: Methodological Shifts and Institutional Challenges New Brunswick, NJ Transaction Publishers
Milekic, M. H. Brown, S. D. Castellini, C. 2006 Persistent disruption of an established morphine conditioned place preference Journal of Neuroscience 26 3010
Mill, J. S. 2001 Utilitarianism Indianapolis Hackett
Milton, A. L. Lee, J. L. Everitt, B. J. 2008 Reconsolidation of appetitive memories for both natural and drug reinforcement is dependent on {beta}-adrenergic receptors Learning and Memory 15 88
Minogue, K. Marshall, E. 2010 Guatemala study from 1940s reflects a ‘dark chapter’ in medicine Science 330 160
Mintzer, M. Z. Copersino, M. L. Stitzer, M. L. 2005 Opioid abuse and cognitive performance Drug and Alcohol Dependence 78 225
Mintzer, M. Z. Stitzer, M. L. 2002 Cognitive impairment in methadone maintenance patients Drug and Alcohol Dependence 67 41
Miotto, K. McCann, M. Basch, J. 2002 Naltrexone and dysphoria: fact or myth? American Journal on Addictions 11 151
Modell, J. G. Glaser, F. B. Mountz, J. M. 1993 The ethics and safety of alcohol administration in the experimental setting to individuals who have chronic, severe alcohol problems Alcohol and Alcoholism 28 189
Montoya, I. D. Haertzen, C. 1994 Reduction of psychopathology among individuals participating in non-treatment drug abuse residential studies Journal of Addictive Disorders 13 89
Montreal Gazette 2006
Moore, D. Aveyard, P. Connock, M. 2009 Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis British Medical Journal 338 b1024
Moreno, A. Y. Azar, M. R. Warren, N. A. 2010 A critical evaluation of a nicotine vaccine within a self-administration behavioral model Molecular Pharmaceutics 7 431
Moreno, J. D. 1999 Bioethics is a naturalism G. McGee Pragmatic Bioethics 5 London Vanderbilt University Press
Morgan, D. Grant, K. A. Gage, H. D. 2002 Social dominance in monkeys: dopamine D-2 receptors and cocaine self-administration Nature Neuroscience 5 169
Morley, K. 2008 Modelling Smoking Behaviour: From Genes and Environment to Pharmacoeconomics Brisbane School of Population Health, The University of Queensland
Moussawi, K. Pacchioni, A. Moran, M. 2009 N-Acetylcysteine reverses cocaine-induced metaplasticity Nature Neuroscience 12 182
Moynihan, R. Cassels, A. 2005 Selling Sickness: How the Drug Companies are Turning us All Into Patients Crows Nest, NSW Allen & Unwin
Mueser, K. T. Drake, R. E. Wallach, M. A. 1998 Dual diagnosis: a review of etiological theories Addictive Behaviors 23 717
Muller, D. Roeder, F. Orthner, H. 1973 Further results of stereotaxis in the human hypothalamus in sexual deviations. First use of this operation in addiction to drugs Neurochirurgia 16 113
Müller, U. J. Sturm, V. Voges, J. 2009 Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: first experience with three cases Pharmacopsychiatry 42 288
Munafò, M. R. 2009 The clinical utility of genetic tests Addiction 104 127
Munafò, M. R. Clark, T. Flint, J. 2005 Promise and pitfalls in the meta-analysis of genetic association studies: a response to Sen and Schinka Molecular Psychiatry 10 895
Munafò, M. R. Matheson, I. J. Flint, J. 2007 Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias Molecular Psychiatry 12 454
Munafò, M. R. Shields, A. E. Berrettini, W. H. 2005 Pharmacogenetics and nicotine addiction treatment Pharmacogenomics 6 211
Munro, C. A. Saxton, J. Butters, M. A. 2000 The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study Alcoholism, Clinical and Experimental Research 24 1510
Murphy, M. R. Checkley, S. A. Seckl, J. R. 1990 Naloxone inhibits oxytocin release at orgasm in man Journal of Clinical Endocrinology and Metabolism 71 1056
Murray, C. J. L. Lopez, A. D. 1996 The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020 Cambridge, MA World Health Organization
Murray, T. 2004 Ethical issues in immunotherapies or depot medications for substance abuse H. J. Harwood T. G. Myers New Treatments for Addiction: Behavioral, Ethical Legal and Social Questions 188 Washington DC National Academies Press
Myrick, H. Anton, R. 2004 Recent advances in the pharmacotherapy of alcoholism Current Psychiatry Reports 6 332
Nace, E. Birkmayer, F. Sullivan, M. 2007 Socially sanctioned coercion mechanisms for addiction treatment American Journal on Addictions 16 15
Naqvi, N. H. Rudrauf, D. Damasio, H. 2007 Damage to the insula disrupts addiction to cigarette smoking Science 315 531
National Advisory Council on Alcohol Abuse and Alcoholism 1989 Recommended Council Guidelines on Ethyl Alcohol Administration in Human Experimentation Rockville, MD National Institute on Alcohol Abuse and Alcoholism
National Advisory Council on Drug Abuse 2005 NACDA Guidelines for Administration of Drugs to Human Subjects Rockville, MD National Institute on Drug Abuse
National Bioethics Advisory Commission 1999 Research Involving Persons with Mental Disorders that may Affect Decision-making Capacity Rockville, MD National Bioethics Advisory Commission
National Health and Medical Research Council 1999 National Statement on Ethical Conduct in Research Involving Humans Canberra National Health and Medical Research Council, Commonwealth of Australia
National Institute on Drug Abuse 2010
National Research Council 2001 Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us Washington, DC National Academy Press
Neale, J. 2002 Drug Users in Society New York Palgrave
Nelkin, D. 1973 Methadone Maintenance: A Technological Fix New York G. Braziller
Nelkin, D. Lindee, M. S. 1996 “Genes made me do it”: the appeal of biological explanations Politics and the Life Sciences 15 95
Nestler, E. J. 2000 Genes and addiction Nature Genetics 26 277
Nestler, E. J. 2004 Molecular mechanisms of drug addiction Neuropharmacology 47 24
Newman, M. Berris, J. 1941 Artificial hibernation therapy Archives of Physiological Therapy 22 161
Newman, R. 1974 Involuntary treatment of drug addiction P. G. Bourne Addiction 113 New York Academic Press
NIAAA 2000 10th Special Report to the US Congress on Alcohol and Health Highlights from the Current Research Bethseda National Institute on Alcohol Abuse and Alcoholism
Nisell, M. Nomikos, G. G. Svensson, T. H. 1994 Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area Synapse 16 36
Noddings, N. 1984 Caring: A Feminine Approach to Ethics and Moral Education Berkeley University of California Press
Numa, R. Kohen, R. Poltyrev, T. 2008 Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization Neuroscience 155 649
Nussbaum, M. 1990 Love's Knowledge: Essays on Philosophy and Literature New York Oxford University Press
Nutt, D. 1996 Addiction: brain mechanisms and their treatment implications Lancet 347 31
Nutt, D. 2003 Death and dependence: current controversies over the selective serotonin reuptake inhibitors Journal of Psychopharmacology 17 355
Nutt, D. 2006 Alcohol alternatives – a goal for psychopharmacology? Journal of Psychopharmacology 20 318
Nutt, D. King, L. A. Saulsbury, W. 2007 Development of a rational scale to assess the harm of drugs of potential misuse Lancet 369 1047
Nutt, D. Lingford-Hughes, A. 2004 Infecting the brain to stop addiction? Proceedings of the National Academy of Sciences of the United States of America 101 11193
Nutt, D. Lingford-Hughes, A. 2008 Addiction: the clinical interface British Journal of Pharmacology 154 397
Nutt, D. Robbins, T. Stimson, G. 2007 Drugs futures 2025 D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 1 London Academic Press
Nutt, D. Robbins, T. Stimson, G. 2007 Drugs and the Future: Brain Science, Addiction and Society London Academic Press
O'Brien, C. P. 2005 Anticraving medications for relapse prevention: a possible new class of psychoactive medications American Journal of Psychiatry 162 1423
O'Brien, C. P. 2008 Prospects for a genomic approach to the treatment of alcoholism Archives of General Psychiatry 65 132
O'Brien, C. P. Childress, A. R. Ehrman, R. 1998 Conditioning factors in drug abuse: can they explain compulsion? Journal of Psychopharmacology 12 15
O'Brien, C. P. Cornish, J. W. 2006 Naltrexone for probationers and parolees Journal of Substance Abuse Treatment 31 107
O'Brien, C. P. Volkow, N. Li, T. K. 2006 What's in a word? Addiction versus dependence in DSM-V American Journal of Psychiatry 163 764
O'Connell, T. J. Bou-Matar, C. B. 2007 Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants Harm Reduction Journal 4 16
O'Connor, P. G. Kosten, T. R. 1998 Rapid and ultrarapid opioid detoxification techniques JAMA 279 229
Olds, J. Milner, P. 1954 Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain Journal of Comparative and Physiological Psychology 47 419
ONDCP 2004 The Economic Costs of Drug Abuse in the United States Washington, DC Office of National Drug Control Policy
Orellana, C. 2002 Controversy over brain surgery for heroin addiction in Russia Lancet Neurology 1 333
Oreskes, N. Conway, E. M. 2010 Merchants of Doubt: How a Handful of Scientists Obscured the Truth on Issues from Tobacco Smoke to Global Warming New York Bloomsbury Press
Orford, J. 2011 An Unsafe Bet: The Dangerous Rise of Gambling and the Debate We Should be Having Chichester John Wiley and Sons
Orson, F. M. Kinsey, B. M. Singh, R. A. K. 2008 Substance abuse vaccines Annals of the New York Academy of Sciences 1141 257
Outram, S. M. 2010 The use of methylphenidate among students: the future of enhancement? Journal of Medical Ethics 36 198
Pacula, R. L. Chriqui, J. F. Reichmann, D. A. 2002 State medical marijuana laws: understanding the laws and their limitations Journal of Public Health Policy 23 413
Pani, P. P. Trogu, E. Vacca, R. 2010
Papp, M. Klimek, V. Willner, P. 1994 Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine Psychopharmacology 115 441
Parens, E. 2002 How far will the treatment/enhancement distinction get us as we grapple with new ways to shape ourselves? S. J. Marcus Neuroethics: Mapping the Field 152 New York Dana Press
Parker, L. A. Siegel, S. 2001 Modulation of the effects of rewarding drugs by ibogaine G. Cordell The Alkaloids: Chemistry and Biology 211 Academic Press
Pascual-Leone, A. Davey, N. Wassermann, E. M. 2002 Handbook of Transcranial Magnetic Stimulation New York Oxford University Press
Passetti, F. Clark, L. Mehta, M. A. 2008 Neuropsychological predictors of clinical outcome in opiate addiction Drug and Alcohol Dependence 94 82
Paulus, M. P. 2007 Decision-making dysfunctions in psychiatry altered homeostatic processing? Science 318 602
Paulus, M. P. Tapert, S. F. Schuckit, M. A. 2005 Neural activation patterns of methamphetamine-dependent subjects during decision making predict relapse Archives of General Psychiatry 62 761
Pedic, F. 1990 Drug Use in Prisons: Data Collection Procedures. A Review and Recommendations Sydney National Drug and Alcohol Research Centre, University of New South Wales
Peele, S. 1998 The Meaning of Addiction: An Unconventional View San Francisco, CA Jossey-Bass Publishers
Peele, S. 2004 The surprising truth about addiction Psychology Today 37 43
Perneger, T. V. Giner, F. del Rio, M. 1998 Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments British Medical Journal 317 13
Persson, I. Savulescu, J. 2011 Unfit for the future? Human nature, scientific progress and the need for moral enhancement J. Savulscu R. ter Meulen G. Kahane Enhancing Human Capacities 486 Oxford Wiley-Blackwell
Pescosolido, B. A. Martin, J. K. Long, J. S. 2010 “A disease like any other?”: a decade of change in public reactions to schizophrenia, depression, and alcohol dependence American Journal of Psychiatry 167 1321
Peto, J. 2001 Cancer epidemiology in the last century and the next decade Nature 411 390
Petry, N. M. 2006 Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction 101 152
Pettinati, H. M. O'Brien, C. P. Rabinowitz, A. R. 2006 The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking Journal of Clinical Psychopharmacology 26 610
Pierce, J. P. Gilpin, E. A. Emery, S. L. 1998 Has the California tobacco control program reduced smoking? JAMA 280 893
Pilla, M. Perachon, S. Sautel, F. 1999 Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 400 371
Pitman, R. K. Sanders, K. M. Zusman, R. M. 2002 Pilot study of secondary prevention of posttraumatic stress disorder with propranolol Biological Psychiatry 51 189
Platt, J. J. Buhringer, G. Kaplan, C. D. 1988 The prospects and limitations of compulsory treatment for drug addiction Journal of Drug Issues 18 505
Pollock, J. D. Ramaswami, M. 2009 The genetics and epigenetics of addiction Journal of Neurogenetics 23 251
Pontius, A. 1973 Neuro-ethics of “walking” in the newborn Perceptual and Motor Skills 37 129
Porrino, L. J. Daunais, J. B. Rogers, G. A. 2005 Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates PLoS Biology 3 1639
Porter, L. Arif, A. Curran, W. J. 1986 The Law and the Treatment of Drug- and Alcohol-Dependent Persons: A Comparative Study of Existing Legislation Geneva WHO
Potenza, M. N. 2006 Should addictive disorders include non-substance-related conditions? Addiction 101 142
Potenza, M. N. 2008 The neurobiology of pathological gambling and drug addiction: an overview and new findings Philosophical Transactions of the Royal Society B-Biological Sciences 363 3181
Potter, V. R. 1970 Bioethics, the science of survival Perspectives in Biology and Medicine 14 127
Presenza, L. J. 2006 Naltrexone as a “mandate” or as a choice: comments on “Judicially mandated naltrexone use by criminal offenders: a legal analysis Journal of Substance Abuse Treatment 31 129
Press, N. 2006 Social construction and medicalization: behavioral genetics in context E. Parens A. R. Chapman N. Press Wrestling with Behavioral Genetics: Science, Ethics and Public Conversation 131 Baltimore Johns Hopkins University Press
Preti, A. 2007 New developments in the pharmacotherapy of cocaine abuse Addiction Biology 12 133
Pritchard, E. Mugavin, J. Swan, A. 2007 Compulsory Treatment in Australia: A Discussion Paper on the Compulsory Treatment of Individuals Dependent on Drugs and/or Alcohol Canberra Australian National Council on Drugs
Productivity Commission 2010 Gambling, Report no. 50 Canberra Australian Government
Rabin, R. L. Sugarman, S. D. 2001 Regulating Tobacco Oxford Oxford University Press
Rachels, J. 1999 The Elements of Moral Philosophy Boston McGraw-Hill
Racine, E. 2003 Discourse ethics as an ethics of responsibility: comparison and evaluation of citizen involvement in population genomics Journal of Law, Medicine and Ethics 31 390
Racine, E. 2008 Which naturalism for bioethics? A defense of moderate (pragmatic) naturalism Bioethics 22 92
Racine, E. 2010 Pragmatic Neuroethics: Improving Treatment and Understanding of the Mind-brain Cambridge MIT Press
Racine, E. Bar-Ilan, O. Illes, J. 2005 fMRI in the public eye Nature Reviews. Neuroscience 6 159
Racine, E. Bar-Ilan, O. Illes, J. 2006 Brain imaging: a decade of coverage in the print media Science Communication 28 122
Racine, E. van der Loos, H. Z. Illes, J. 2007 Internet marketing of neuroproducts: new practices and healthcare policy challenges Cambridge Quarterly of Healthcare Ethics 16 181
Ragan, I. 2007 Drugs futures 2025? Perspectives of the pharmaceutical industry D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 507 London Academic Press
Rapeli, P. Kivisaari, R. Autti, T. 2006 Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls BMC Psychiatry 6 9
Rasmussen, N. 2008 On Speed: The Many Lives of Amphetamine New York New York University Press
Rassool, G. H. 2007 Some considerations on attitudes to addictions: waiting for the tide to change Journal of Addictions Nursing 18 61
Rawls, J. 1971 A Theory of Justice Cambridge, MA Belknap Press of the Harvard University Press
Rawson, R. A. McCann, M. J. Hasson, A. J. 2000 Addiction pharmacotherapy 2000: new options, new challenges Journal of Psychoactive Drugs 32 371
Read, J. Law, A. 1999 The relationship of causal beliefs and contact with users of mental health services to attitudes to the ‘mentally ill’ International Journal of Social Psychiatry 45 216
Rehm, J. Room, R. van den Brink, W. 2005 Problematic drug use and drug use disorders in EU countries and Norway: an overview of the epidemiology European Neuropsychopharmacology 15 389
Renthal, W. Nestler, E. J. 2008 Epigenetic mechanisms in drug addiction Trends in Molecular Medicine 14 341
Resnik, D. B. 1998 The Ethics of Science: An Introduction New York Routledge
Reverby, S. 2009 Examining Tuskegee: The Infamous Syphilis Study and its Legacy Chapel Hill University of North Carolina Press
Reynolds, A. 1992 Interface between health and law Winter School in the Sun Brisbane Alcohol and Drug Foundation of Queensland
Rhee, S. H. Hewitt, J. K. Young, S. E. 2003 Genetic and environmental influences on substance initiation, use, and problem use in adolescents Archives of General Psychiatry 60 1256
Ridding, M. C. Rothwell, J. C. 2007 Is there a future for therapeutic use of transcranial magnetic stimulation? Nature Reviews. Neuroscience 8 559
Ridgely, M. Iguchi, M. Chiesa, J. 2004 The use of immunotherapies and sustained-release formulations in the treatment of drug addiction: will current law support coercion? H. J. Harwood T. G. Myers New Treatments for Addiction: Behavioral, Ethical, Legal, and Social Questions 173 Washington, DC National Academies Press
Risinger, R. C. Salmeron, B. J. Ross, T. J. 2005 Neural correlates of high and craving during cocaine self-administration using BOLD fMRI Neuroimage 26 1097
Robbins, T. W. Cardinal, R. N. DiCiano, P. 2007 Neuroscience of drugs and addiction D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 11 London Academic Press
Robbins, T. W. Everitt, B. J. 1999 Drug addiction: bad habits add up Nature 398 567
Robbins, T. W. Everitt, B. J. 2002 Limbic-striatal memory systems and drug addiction Neurobiology of Learning and Memory 78 625
Roberts, L. W. 2002 Addiction and consent American Journal of Bioethics 2 58
Roberts, L. W. 2002 Informed consent and the capacity for voluntarism American Journal of Psychiatry 159 705
Roberts, L. W. Dunn, L. B. 2003 Ethical considerations in caring for women with substance use disorders Obstetrics and Gynecology Clinics of North America 30 559
Robinson, S. Sandstrom, S. M. Denenberg, V. H. 2005 Distinguishing whether dopamine regulates liking, wanting, and/or learning about rewards Behavioral Neuroscience 119 5
Robinson, T. E. Berridge, K. C. 2000 The psychology and neurobiology of addiction: an incentive-sensitization view Addiction 95 S91
Robinson, T. E. Kolb, B. 2004 Structural plasticity associated with exposure to drugs of abuse Neuropharmacology 47 33
Rogers, R. D. Everitt, B. J. Baldacchino, A. 1999 Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms Neuropsychopharmacology 20 322
Rogers, R. D. Robbins, T. W. 2001 Investigating the neurocognitive deficits associated with chronic drug misuse Current Opinion in Neurobiology 11 250
Rollema, H. Coe, J. W. Chambers, L. K. 2007 Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation Trends in Pharmacological Sciences 28 316
Room, R. 2005 Stigma, social inequality and alcohol and drug use Drug and Alcohol Review 24 143
Room, R. 2006 Taking account of cultural and societal influences on substance use diagnoses and criteria Addiction 101 31
Room, R. 2007 Social policy and psychoactive substances D. Nutt T. Robbins G. Stimson Drugs and the Future: Brain Science, Addiction and Society 337 London Academic Press
Room, R. Fischer, B. Hall, W. 2010 Cannabis Policy: Moving Beyond Stalemate Oxford Oxford University Press
Room, R. Greenfield, T. Weisner, C. 1991 People who might have liked you to drink less: changing responses to drinking by US family members and friends Contemporary Drug Problems 573
Roper, P. 1966 Drug addiction, psychotic illness and brain self-stimulation: effective treatment and explanatory hypothesis Canadian Medical Association Journal 95 1080
Rosack, J. 2007 FDA panel recommends against depression-treatment device Psychiatric News 42 2
Rose, G. 1992 The Strategy of Preventive Medicine Oxford Oxford University Press
Rose, N. 2003 The neurochemical self and its anomalies R. Ericson Risk and Morality 407 Toronto University of Toronto Press
Roskies, A. L. 2007 Neuroethics beyond genethics. Despite the overlap between the ethics of neuroscience and genetics, there are important areas where the two diverge EMBO Reports 8 S52
Ross, P. 2003 Mind readers Scientific American 289 74
Rotgers, F. 1992 Coercion in addictions treatment F. Rotgers J. W. Langebucher B. S. McCrady Annual Review of the Addictions Research and Treatment 403 New York Pergamon Press
Rothstein, M. A. 1998 Genetic privacy and confidentiality: why they are so hard to protect Journal of Law Medicine & Ethics 26 198
Rothstein, M. A. 2008 Putting the Genetic Information Non-discrimination Act in context Genetics in Medicine 10 655
Rothstein, M. A. Anderlik, M. R. 2001 What is genetic discrimination, and when and how can it be prevented? Genetics in Medicine 3 354
Rouaud, T. Lardeux, S. Panayotis, N. 2010 Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation Proceedings of the National Academy of Sciences 107 1196
Safire, W. 2002 Visions for a new field of “neuroethics S. J. Marcus Neuroethics: Mapping the Field San Fransisco The Dana Press
Sahakian, B. J. Morein-Zamir, S. 2007 Professor's little helper Nature 450 1157
Salomon, L. Lanteri, C. Glowinski, J. 2006 Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons Proceedings of the National Academy of Sciences 103 7476
SAMSHA 2006 Results from the 2005 National Survey on Drugs Use and Health: National Findings Rockville, MD Office of Applied Studies, Substance Abuse and Mental Health Services Administration
Sani, S. Jobe, K. Smith, A. 2007 Deep brain stimulation for treatment of obesity in rats Journal of Neurosurgery 107 809
Sarnyai, Z. 1998 Oxytocin and neuroadaptation to cocaine Progress in Brain Research 119 449
Sarnyai, Z. Kovacs, G. L. 1994 Role of oxytocin in the neuroadaptation to drugs of abuse Psychoneuroendocrinology 19 85
Sartorius, N. 2010 Short-lived campaigns are not enough Nature 468 163
Satel, S. 1999 The fallacies of no-fault addiction Public Interest 52
Satel, S. Lilenfeld, S. 2007
Savulescu, J. 2005 New breeds of humans: the moral obligation to enhance Reproductive Biomedicine Online 10 36
Schaub, M. Stevens, A. Berto, D. 2010 Comparing outcomes of ‘voluntary’and ‘quasi-compulsory’treatment of substance dependence in Europe European Addiction Research 16 53
Scherbaum, N. Klein, S. Kaube, H. 1998 Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification Pharmacopsychiatry 31 205
Scherbaum, N. Rist, F. 2010 Opiate addicts' attitudes towards heroin prescription Open Addiction Journal 3 109
Schiff, N. D. Giacino, J. T. Fins, J. J. 2009 Deep brain stimulation, neuroethics, and the minimally conscious state: moving beyond proof of principle Archives of Neurology 66 697
Schlaepfer, T. E. Cohen, M. X. Frick, C. 2008 Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression Neuropsychopharmacology 33 368
Schoenbaum, G. Roesch, M. R. Stalnaker, T. A. 2006 Orbitofrontal cortex, decision-making and drug addiction Trends in Neurosciences 29 116
Schultz, W. 2006 Behavioral theories and the neurophysiology of reward Annual Review of Psychology 57 87
Schultz, W. 2007 Behavioral dopamine signals Trends in Neurosciences 30 203
Schultz, W. 2010 Dopamine signals for reward value and risk: basic and recent data Behavioral and Brain Functions 6 24
Schultz, W. Dayan, P. Montague, P. R. 1997 A neural substrate of prediction and reward Science 275 1593
Schumann, G. 2007 Okey Lecture 2006: identifying the neurobiological mechanisms of addictive behaviour Addiction 102 1689
Schupbach, M. Gargiulo, M. Welter, M. L. 2006 Neurosurgery in Parkinson disease: a distressed mind in a repaired body? Neurology 66 1811
Schutz, C. 2008 Using neuroimaging to predict relapse to smoking: role of possible moderators and mediators International Journal of Methods in Psychiatric Research 17 S78
Scott, C. K. White, W. L. 2005 Ethical issues in the conduct of longitudinal studies of addiction treatment Journal of Substance Abuse Treatment 28 S91
See, R. E. 2005 Neural substrates of cocaine-cue associations that trigger relapse European Journal of Psychopharmacology 526 140
Servello, D. Porta, M. Sassi, M. 2008 Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation Journal of Neurology, Neurosurgery & Psychiatry 79 136
Sevy, S. Smith, G. S. Ma, Y. 2008 Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography Psychopharmacology 197 549
Shaham, Y. Hope, B. T. 2005 The role of neuroadaptations in relapse to drug seeking Nature Neuroscience 8 1437
Sharma, T. 1974 Abolition of opiate hunger in humans following bilateral anterior cingulotomy Texas Medicine 70 49
Sheldon, J. 1987 Legal and ethical issues in the behavioural treatment of juvenile and adult offenders E. Morris C. Braukmann Behavioural Approaches to Crime and Delinquency Sydney NSW Drug and Alcohol Authority
Sherman, W. 2006
Shorter, E. Healy, D. 2007 Shock Therapy: A History of Electroconvulsive Therapy in Mental Illness New Brunswick Rutgers University Press
Sigmon, S. C. Moody, D. E. Nuwayser, E. S. 2006 An injection depot formulation of buprenorphine: extended biodelivery and effects Addiction 101 420
Singer, P. 1993 A Companion to Ethics Oxford Blackwell
Singer, T. Kiebel, S. J. Winston, J. S. 2004 Brain responses to the acquired moral status of faces Neuron 41 653
Singh, I. Rose, N. 2009 Biomarkers in psychiatry Nature 460 202
Skene, L. 1987 An evaluation of a Victorian scheme for diversion of alcoholic and drug dependent offenders Australian and New Zealand Journal of Criminology 20 247
Slotema, C. W. Blom, J. D. Hoek, H. W. 2010 Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders Journal of Clinical Psychiatry 71 873
Small, W. Kain, S. Laliberte, N. 2005 Incarceration, addiction and harm reduction: inmates' experience injecting drugs in prison Substance Use & Misuse 40 831
Smeding, H. M. Goudriaan, A. E. Foncke, E. M. 2007 Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease Journal of Neurology, Neurosurgery & Psychiatry 78 517
Smeding, H. M. Speelman, J. D. Koning-Haanstra, M. 2006 Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study Neurology 66 1830
Smith, K. L. Horton, N. J. Saitz, R. 2006 The use of the mini-mental state examination in recruitment for substance abuse research studies Drug and Alcohol Dependence 82 231
Smith, L. Watson, M. Gates, S. 2008 Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review American Journal of Epidemiology 167 125
Sobel, B. F. Sigmon, S. C. Walsh, S. L. 2004 Open-label trial of an injection depot formulation of buprenorphine in opioid detoxification Drug and Alcohol Dependence 73 11
Sobell, L. C. 2007 The phenomenon of self-change: overview and key issues H. Klingemann L. C. Sobell Promoting Self-Change From Addictive Behaviors 1 New York, NY Springer
Sofuoglu, M. Kosten, T. R. 2006 Emerging pharmacological strategies in the fight against cocaine addiction Expert Opinion on Emerging Drugs 11 91
Sowell, E. R. Thompson, P. M. Toga, A. W. 2004 Mapping changes in the human cortex throughout the span of life Neuroscientist 10 372
Spooner, C. Hall, W. Mattick, R. P. 2001 An overview of diversion strategies for Australian drug-related offenders Drug and Alcohol Review 20 281
Spooner, C. Lynskey, M. Hall, W. 2001 Structural Determinants of Youth Drug Use Canberra Australian National Council on Drugs
Spriggs, M. 2003 Can we help addicts become more autonomous? Inside the mind of an addict Bioethics 17 542
Spriggs, M. 2005 Autonomy and Patients' Decisions Lanham, MD Lexington Books
Srisurapanont, M. Jarusuraisin, N. 2005 Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials International Journal of Neuropsychopharmacology 8 267
Stamford, J. A. Muscat, R. O'Connor, J. J. 1991 Voltammetric evidence that subsensitivity to reward following chronic mild stress is associated with increased release of mesolimbic dopamine Psychopharmacology 105 275
Stapleton, J. A. 2009 Trial comes too late as psychiatric side effects end hope for rimonabant Addiction 104 277
Stathis, H. 1991 Drug Use Among Offenders: A Literature Review Sydney Research and Statistics Division, NSW Department of Corrective Services
Stathis, H. Bertram, S. Eyland, S. 1991 Patterns of Drug Use Amongst NSW Prison Receptions NSW Research and Statistics Division, NSW Department of Corrective Services
Steensland, P. Simms, J. A. Holgate, J. 2007 Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking Proceedings of the National Academy of Sciences of the United States of America 104 12518
Stelten, B. M. Noblesse, L. H. Ackermans, L. 2008 The neurosurgical treatment of addiction Neurosurgical Focus 25 E5
Stevens, J. 1987 Storming Heaven: LSD and the American Dream New York William Heinemann
Stitzer, M. Iguchi, M. Kidorf, M. 1993 Contingency management in methadone treatment: the case for positive incentives L. Onken J. Blaine J. Boren Behavioral Treatments for Drug Abuse and Dependence 19 Rockville, MD National Indicate of Drug Abuse
Stock, G. 2002 Redesigning Humans: Choosing our Children's Genes London Profile Books
Stratton, K. Shetty, P. Wallace, R. J. 2001 Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction Washington, DC National Academy Press
Sugarman, J. McCrory, D. C. Powell, D. 1999 Empirical research on informed consent. An annotated bibliography Hastings Center Report 29 S1
Sullivan, M. Birkmayer, F. Boyarsky, B. 2008 Uses of coercion in addiction treatment: clinical aspects American Journal on Addictions 17 36
Swayze, V. W. 1995 Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935–1954): a historical overview American Journal of Psychiatry 152 505
Synofzik, M. Schlaepfer, T. E. 2008 Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes Biotechnology Journal 3 1511
Synofzik, M. Schlaepfer, T. E. 2011 Electrodes in the brain: ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders Brain Stimulation 4 7
Szasz, T. S. 1975 Ceremonial Chemistry: The Ritual Persecution of Drugs, Addicts, and Pushers London Routledge
Tassin, J. -P. 2008 Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse Biochemical Pharmacology 75 85
Taylor, S. 1998 A case study of genetic discrimination: social work and advocacy within a new context Australian Social Work 51 51
Taylor, S. Treloar, S. Barlow-Stewart, K. 2008 Investigating genetic discrimination in Australia: a large-scale survey of clinical genetics clients Clinical Genetics 74 20
Teesson, M. Hall, W. Degenhardt, L. 2002 Addictions Hove Psychology Press
Tercyak, K. P. Peshkin, B. N. Abraham, A. 2007 Interest in genetic counseling and testing for adolescent nicotine addiction susceptibility among a sample of adolescent medicine providers attending a scientific conference on adolescent health Journal of Adolescent Health 41 42
Tercyak, K. P. Peshkin, B. N. Wine, L. A. 2006 Interest of adolescents in genetic testing for nicotine addiction susceptibility Preventive Medicine 42 60
Thigpen, F. Thigpen, C. Cleckley, H. 1953 Use of electric-convulsive therapy in morphine, meperidine, and related alkaloid addictions Archives of Neurology and Psychiatry 70 452
Thomas, M. J. Buckmaster, L. 2007 ‘Naltrexone or methadone’? Debates about drug treatments for heroin dependence in the context of drugs policy Parliamentary Library: Information, Analysis and Advice for the Parliament 7 1
Thomasson, H. R. Edenberg, H. J. Crabb, D. W. 1991 Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men American Journal of Human Genetics 48 677
Tiffany, S. T. 1990 A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes Psychological Review 97 147
TILLIM, S. 1942 Opiate withdrawal treated with induced hypoglycemic reactions American Journal of Psychiatry 99 84
Time 1939,9171,761978,00.html
Tracy, S. 2005 Alcoholism in America: From Reconstruction to Prohibition Baltimore Johns Hopkins University Press
Trujillo, K. A. Akil, H. 1991 Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801 Science 251 85
Trujillo, K. A. Akil, H. 1995 Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence Drug and Alcohol Dependence 38 139
Tsankova, N. Renthal, W. Kumar, A. 2007 Epigenetic regulation in psychiatric disorders Nature Reviews. Neuroscience 8 355
Turner, S. Longshore, D. Wenzel, S. 2002 A decade of drug treatment court research Substance Use & Misuse 37 1489
Tyndale, R. F. 2003 Genetics of alcohol and tobacco use in humans Annals of Medicine 35 94
Udesky, L. 2010 The ethics of direct-to-consumer genetic testing Lancet 376 1377
Uhl, G. R. Grow, R. W. 2004 The burden of complex genetics in brain disorders Archives of General Psychiatry 61 223
Uhl, G. R. Li, M. D. Gelertner, J. 2004 Molecular genetics of addiction vulnerability and treatment responses Neuropsychopharmacology 29 S26
UNCHR 1996 HIV/AIDS in Prisons. Statement by the Joint United Nations Programme on HIV/AIDS Strasbourg United Nations Commission on Human Rights
United Nations General Assembly 1948
UNODC 2006 HIV/AIDS and Custodial Settings in South East Asia: An Exploratory Review into the Issue of HIV/AIDS and Custodial Settings in Cambodia, China, Lao PDR, Myanmar, Thailand and Viet Nam Thailand United Nations Office on Drugs and Crime
UNODC 2006 HIV/AIDS Prevention, Care, Treatment and Support in Prison Settings: A Framework for an Effective National Response Vienna World Health Organization and the Joint United Nations Programme on HIV/AIDS
UNODC 2010 From Coercion to Cohesion: Treating Drug Dependence Through Healthcare, Not Punishment: Discussion Paper Vienna United Nations Office on Drugs and Crime
UNODC and WHO 2008 Principles of Drug Dependence Treatment Vienna United Nations Office on Drugs and Crime
Urbanoski, K. A. 2010 Coerced addiction treatment: client perspectives and the implications of their neglect Harm Reduction Journal 7 13
Valenstein, E. S. 1973 Brain Control: A Critical Examination of Brain Stimulation and Psychosurgery New York Wiley
Valenstein, E. S. 1986 Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness New York Basic Books
Valenstein, E. S. 1998 Blaming the Brain: The Truth About Drugs and Mental Health New York Free Press
Van Hoyweghen, I. Horstman, K. 2008 European practices of genetic information and insurance JAMA 300 326
Vassoler, F. M. Schmidt, H. D. Gerard, M. E. 2008 Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats Journal of Neuroscience 28 8735
Vastag, B. 2002 Addiction treatment strives for legitimacy JAMA 288 3096
Vastag, B. 2005 Addiction research. Ibogaine therapy: a ‘vast, uncontrolled experiment’ Science 308 345
Vergne, D. E. Anton, R. F. 2010 Aripiprazole: a drug with a novel mechanism of action and possible efficacy for alcohol dependence CNS and Neurological Disorders Drug Targets 9 50
Verweij, M. 1999 Medicalization as a moral problem for preventive medicine Bioethics 13 89
Vineis, P. Schulte, P. McMichael, A. J. 2001 Misconceptions about the use of genetic tests in populations Lancet 357 709
Visser-Vandewalle, V. Ackermans, L. van der Linden, C. 2006 Deep brain stimulation in Gilles de la Tourette's syndrome Neurosurgery 58 E590
Vlahov, D. Wang, C. L. Galai, N. 2004 Mortality risk among new onset injection drug users Addiction 99 946
Vocci, F. Chiang, C. N. 2001 Vaccines against nicotine: how effective are they likely to be in preventing smoking? CNS Drugs 15 505
Vocci, F. Ling, W. 2005 Medications development: successes and challenges Pharmacology & Therapeutics 108 94
Volkow, N. D. Chang, L. Wang, G. J. 2001 Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers American Journal of Psychiatry 158 377
Volkow, N. D. Fowler, J. S. 2000 Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex Cerebral Cortex 10 318
Volkow, N. D. Fowler, J. S. Wang, G. J. 2003 The addicted human brain: insights from imaging studies Journal of Clinical Investigation 111 1444
Volkow, N. D. Fowler, J. S. Wang, G. J. 2004 The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies Neuropharmacology 47 3
Volkow, N. D. Fowler, J. S. Wang, G. J. 2009 Imaging dopamine's role in drug abuse and addiction Neuropharmacology 56 3
Volkow, N. D. Fowler, J. S. Wang, G. J. 2004 Dopamine in drug abuse and addiction: results from imaging studies and treatment implications Molecular Psychiatry 9 557
Volkow, N. D. Fowler, J. S. Wang, G. J. 2007 Dopamine in drug abuse and addiction: results of imaging studies and treatment implications Archives of Neurology 64 1575
Volkow, N. D. Fowler, J. S. Wolf, A. P. 1991 Changes in brain glucose metabolism in cocaine dependence and withdrawal American Journal of Psychiatry 148 621
Volkow, N. D. Li, T. -K. 2005 Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences Pharmacology & Therapeutics 108 3
Volkow, N. D. Li, T. K. 2004 Drug addiction: the neurobiology of behaviour gone awry Nature Reviews. Neuroscience 5 963
Volkow, N. D. O'Brien, C. P. 2007 Issues for DSM-V: should obesity be included as a brain disorder? American Journal of Psychiatry 164 708
Volkow, N. D. Wise, R. A. 2005 How can drug addiction help us understand obesity Nature Neuroscience 8 555
Volpicelli, J. R. Clay, K. L. Watson, N. T. 1995 Naltrexone in the treatment of alcoholism: predicting response to naltrexone Journal of Clinical Psychiatry 56 39
Vorel, S. R. Ashby, C. R., Jr. Paul, M. 2002 Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats Journal of Neuroscience 22 9595
Vos, T. Carter, R. Barendregt, J. 2010 Assessing Cost-effectiveness in Prevention: ACE–prevention September 2010 Final Report Brisbane The University of Queensland
Vosburg, S. K. Hart, C. L. Haney, M. 2010 Modafinil does not serve as a reinforcer in cocaine abusers Drug and Alcohol Dependence 106 233
Vrecko, S. 2008 Capital ventures into biology: biosocial dynamics in the industry and science of gambling Economy and Society 37 50
Vrecko, S. 2010 Birth of a brain disease: science, the state and addiction neuropolitics History of the Human Sciences 23 52
Walker, R. Logan, T. K. Clark, J. J. 2005 Informed consent to undergo treatment for substance abuse: a recommended approach Journal of Substance Abuse Treatment 29 241
Walker, T. 2008 Giving addicts their drug of choice: the problem of consent Bioethics 22 314
Wallace, A. L. 2004 Epidemiological and Economic Modelling of the Potential Impact of a Nicotine Vaccine on Smoking Cessation and Related Mortality and Morbidity in the Australian Population Brisbane School of Population Health, The University of Queensland
Walsh, N. P. 2002,771816,00.html
Ward, J. Mattick, R. P. Hall, W. 1992 Key Issues in Methadone Maintenance Treatment Kensington, NSW New South Wales University Press
Ward, J. Mattick, R. P. Hall, W. 1998 Methadone Maintenance Treatment and Other Opioid Replacement Therapies Sydney Harwood Academic Press
Ward, J. Mattick, R. P. Hall, W. 1998 The use of urinalysis during opioid replacement therapy J. Ward R. P. Mattick W. Hall Methadone Maintenance Treatment and Other Opioid Replacement Therapies Sydney Harwood Academic Press
Wark, P. 2009
Watkins, E. S. 2010 Technophilia and the pharmaceutical fix Lancet 376 1638
Weisberg, D. S. Keil, F. C. Goodstein, J. 2008 The seductive allure of neuroscience explanations Journal of Cognitive Neuroscience 20 470
Weisner, C. 1990 Coercion in alcohol treatment Institute of Medicine Broadening the Base of Treatment for Alcohol Problems 579 Washington, DC National Academy Press
Weiss, F. Maldonado-Vlaar, C. S. Parsons, L. H. 2000 Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens Proceedings of the National Academy of Sciences of the United States of America 97 4321
Welton, N. J. Johnstone, E. C. David, S. P. 2008 A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation Nicotine & Tobacco Research 10 231
Wesson, D. R. Ling, W. 2003 The clinical opiate withdrawal scale (COWS) Journal of Psychoactive Drugs 35 253
West, R. 2006 Theory of Addiction Carlton, Victoria Blackwell Publishing
Wexler, D. 1993 Therapeutic jurisprudence and changing conceptions of legal scholarship Behavioural Science and the Law 11 17
Whalen, P. J. Rauch, S. L. Etcoff, N. L. 1998 Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge Journal of Neuroscience 18 411
White, J. Bell, J. Saunders, J. B. 2009 Open-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependence Drug and Alcohol Dependence 103 37
White, N. 1996 Addictive drugs as reinforcers: multiple partial actions on memory systems Addiction 91 921
White, V. Hill, D. Siahpush, M. 2003 How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001 Tobacco Control 12 ii67
White, W. L. 1998 Slaying the Dragon: The History of Addiction Treatment and Recovery in America Bloomington, IL. Chestnut Health Systems/Lighthouse Institute
White, W. L. 2003 The history of ‘medicinal specifics’ as addiction cures in the United States Addiction 98 261
WHO 1993 The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research Geneva World Health Organization
WHO 1995 European Charter on Alcohol Copenhagen World Health Organization Regional Office for Europe
WHO 2004 Developing the Ethical Review Process Geneva World Health Organization
WHO 2004 Neuroscience of Psychoactive Substance Use and Dependence Geneva World Health Organization
WHO 2005 Basic Principles for Treatment and Psychosocial Support of Drug Dependent People Living with HIV/AIDS Geneva World Health Organization
WHO 2006 HIV/AIDS Treatment and Care for Injecting Drug Users: Clinical Protocol for the WHO European Region Copenhagen World Health Organization Regional Office for Europe
WHO 2008 Guidelines for the Psychosocially-assisted Pharmacological Treatment of Opioid Dependence Geneva World Health Organization
WHO 2009
Wild, T. C. 1999 Compulsory substance-user treatment and harm reduction: a critical analysis Substance Use & Misuse 34 83
Wild, T. C. 2006 Social control and coercion in addiction treatment: towards evidence-based policy and practice Addiction 101 40
Wild, T. C. Newton-Taylor, B. Alletto, R. 1998 Perceived coercion among clients entering substance abuse treatment: structural and psychological determinants Addictive Behaviors 23 81
Wilfond, B. Geller, G. Lerman, C. 2002 Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents Journal of Health Care Law and Policy 6 73
Willett, W. C. 2002 Balancing life-style and genomics research for disease prevention Science 296 695
Williams, J. Pacula, R. L. Chaloupka IV, F. J. 2001 Alcohol and Marijuana Use Among College Students: Economic Complements or Substitutes? Cambridge, MA National Bureau of Economic Research
Williams, T. M. Daglish, M. R. Lingford-Hughes, A. 2007 Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study British Journal of Psychiatry 191 63
Willner, P. 1997 The mesolimbic dopamine system as a target for rapid antidepressant action International Clinical Psychopharmacology 12 S7
Willner, P. Hale, A. S. Argyropoulos, S. 2005 Dopaminergic mechanism of antidepressant action in depressed patients Journal of Affective Disorders 86 37
Wilson, D. B. Mitchell, O. MacKenzie, D. L. 2006 A systematic review of drug court effects on recidivism Journal of Experimental Criminology 2 459
Wind, J. J. Anderson, D. E. 2008 From prefrontal leukotomy to deep brain stimulation: the historical transformation of psychosurgery and the emergence of neuroethics Neurosurgical Focus 25 E10
Wise, R. A. 1996 Neurobiology of addiction Current Opinion in Neurobiology 6 243
Wise, R. A. 2004 Dopamine, learning and motivation Nature Reviews. Neuroscience 5 483
Wise, R. A. Bozarth, M. A. 1987 A psychomotor stimulant theory of addiction Psychological Review 94 469
Wishart, H. A. Roberts, D. W. Roth, R. M. 2003 Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports Journal of Neurology, Neurosurgery and Psychiatry 74 1392
Witjas, T. Baunez, C. Henry, J. M. 2005 Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation Movement Disorders 20 1052
Wodak, A. D. Ali, R. Henry, D. 2008 Ensuring the safety of new medications and devices: are naltrexone implants safe? Medical Journal of Australia 188 438
Wolf, M. E. 1998 The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants Progress in Neurobiology 54 679
Wolfe, D. 2007 Paradoxes in antiretroviral treatment for injecting drug users: access, adherence and structural barriers in Asia and the former Soviet Union International Journal of Drug Policy 18 246
Wolfe, D. Carrieri, M. Shepard, D. 2010 Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward Lancet 376 355
Wolpe, P. R. 2002 Treatment, enhancement, and the ethics of neurotherapeutics Brain and Cognition 50 387
Wood, E. Montaner, J. Kerr, T. 2005 HIV risks in incarcerated injection-drug users Lancet 366 1834
Wood, M. D. Sher, K. J. 2000 Risks of alcohol consumption in laboratory studies involving human research participants Psychology of Addictive Behaviors 14 328
Wright, A. J. Aveyard, P. Guo, B. 2007 Is attributing smoking to genetic causes associated with a reduced probability of quit attempt success? A cohort study Addiction 102 1657
Wright, A. J. Weinman, J. Marteau, T. M. 2003 The impact of learning of a genetic predisposition to nicotine dependence: an analogue study Tobacco Control 12 227
Wu, H.-M. Wang, X.-L. Chang, C.-W. 2010 Preliminary findings in ablating the nucleus accumbens using stereotactic surgery for alleviating psychological dependence on alcohol Neuroscience Letters 473 77
Xinhua News Agency 2005
Xu, Z. Hou, B. Gao, Y. 2007 Effects of enriched environment on morphine-induced reward in mice Experimental Neurology 204 714
Yahyavi-Firouz-Abadi, N. See, R. E. 2009 Anti-relapse medications: preclinical models for drug addiction treatment Pharmacology & Therapeutics 124 235
Yamamoto, T. Kobayashi, K. Kasai, M. 2005 DBS therapy for the vegetative state and minimally conscious state Acta Neurochirurgica. Supplement 93 101
Yeomans, M. R. Gray, R. W. 2002 Opioid peptides and the control of human ingestive behaviour Neuroscience and Biobehavioral Reviews 26 713
Yucel, M. Lubman, D. I. 2007 Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention Drug and Alcohol Review 26 33
Zubieta, J. Gorelick, D. A. Stauffer, R. 1996 Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving Nature Medicine 2 1225
Zubieta, J. Greenwald, M. K. Lombardi, U. 2000 Buprenorphine-induced changes in mu-opioid receptor availability in male heroin-dependent volunteers: a preliminary study Neuropsychopharmacology 23 326
Zullino, D. F. Krenz, S. Zimmerman, G. 2005 Topiramate in opiate withdrawal – comparison with clonidine and with carbamazepine/mianserin Substance Abuse 25 27